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ABSTRACT

BOVINE ENTEROPATHOGENIC CORONAVIRUS:

THE EFFECT

OF THE HOST CELL AND TRYPSIN MODIFICATION ON THE VIRUS
STRUCTURE, CYTOPATHIC EXPRESSION, AND INFECTIVITY

by

Karen St. Cyr-Coats

Human rectal tumor-18 (HRT-18) cell clones 3F3, 3E3, D2, and 4B3
exhibited differences in cellular morphology in Giemsa-stained cultures
and developing monolayers.

Differences were evident in growth kinetics

and plating efficiency of each clone.

The clones produced colonies in

soft agar, demonstrating anchorage independence.

Cytopathic expression

(CPE) including cytoplasmic

vacuolization

and cell fusion

occurredin

BCV-L9-infected clones 3F3,

D2, and 3E3. Cell fusion was inapparent in

clone 4B3.
Bovine coronavirus strain L9 (BCV-L9) and 5 wild-type isolates
replicated in HRT-18 cells,

inducing cell fusion.

Strain L9,

exclusively, replicated in D2BFS cells, requiring trypsin to induce cell
fusion.

Strain L9 produced plaques in the HRT-18 clones, but the ease

of plaque formation and plaque morphology was host cell dependent.

Host

cell- dependent plaque formation was demonstrated by wild-type BCV
strains, and plaque morphology was strain dependent.
xiv

The intensity of

trypsin enhancement of CPE and plaque development depended on the virus
strain and host cell.
Trypsin greatly enhanced the infectivity of BCV-L9 in D2BFS and
HRT-18 cells, and to lesser extents in clones 3F3, 3E3, and D2.
Trypsin-enhanced infectivity was not detected in clone 4B3.

The

infectivity of strain LY-138 in HRT-18 cells was slightly enhanced by
trypsin.
Eleven structural proteins of BCV-L9 were detected by
immunoblot ting, including 185, 160, 140, 125, 110, 100, 52, 46, 37,
31-34, and 26-28 Kd species.

Under reducing conditions 185, 140, and

100 Kd species migrated as 190, 65, and 95 Kd forms.

Silver-stained

proteins of 18, 20, and 23 Kd were reduced to a 20-23 Kd cluster.
Host cell-dependent differences in the protein profile of L9 were
detected.

A 62 Kd protein was specific to L9 (D2BFS with trypsin).

L9

(4B3) and L9 (D2) lacked the 46 and 110 Kd bands, respectively.
Cleavage of the 185 Kd protein, an increase in the 100 Kd band, and
conversion of the 31-34 Kd cluster to a 34 Kd band occurred when BCV-L9
was propagated in D2BFS cells with trypsin.

Trypsin converted the

reduced, 95 Kd protein found in L9 (HRT-18) to 90 Kd, and the 20-23 Kd
cluster was altered to 19-23 Kd.

In vitro trypsin treatment of L9 (3F3)

resulted j'.n cleavage of the 46 Kd molecule and the appearance of a 25 Kd
species.

xv

CHAPTER I.

INTRODUCTION

Bovine enteropathogenic coronavirus (BCV), a member of the family
Coronaviridae, is a major cause of gastroenteritis in newborn calves.
The virus induces a severe diarrhea with dehydration and malabsorption
resulting from destruction of villous enterocytes of the small intestine
and colon (3,32,85).

The high morbidity and mortality rate associated

with this disease makes it of significant economic importance in the
cattle industries (7,14).
Factors affecting the virulence of BCV are largely undefined.
Study of the virus was hampered by the difficulty of propagating the
virus in culture.

The inclusion of trypsin in culture medium has aided

in the propagation of virus.

Trypsin enhances the replication,

cell-fusing activity, and plaque development of many BCV strains
(97,124,135).

Some viral proteins are altered in their electrophoretic

mobility following trypsin treatment (133).
The effect of trypsin on the infectivity of the virus has not been
clearly defined.

Trypsin and other proteases are normally found in the

intestine - the site of coronavirus replication in the natural
infection.

Therefore, this enzyme may influence the virulence of the

virus in the natural host.
In 1974 Tompkins and coworkers (122) established the human rectal
turaor-18 (HRT-18) cell line from an adenocarcinoma of the lower
gastrointestinal tract.

These cells are permissive to many BCV strains,

greatly improving in vitro culture methods for the virus.
Immunofluorescent examination of plaques formed by BCV in HRT-18
monolayers reveals that not all of the cells express viral antigen.
1
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This finding indicates that subpopulations of HRT-18 cells may exist
which differ in susceptibility to BCV.
The replication and cytopathic effects of coronaviruses are highly
dependent on both the host cell type and the virus strain.
Host-dependent differences in proteolytic processing have been reported
for mouse hepatitis virus strain A59 (MHV-A59) when the virus was
propagated in different murine cell lines (37,117).

Cleavage of the 180

Kd peplomeric protein contributes to activation of cell fusion (37).
Proteolytic processing is necessary for activating cell-fusing activity
and infectivity of both orthomyxoviruses and paramyxoviruses, as well as
a number of other viruses (24,25,39,51-54,92,93,98,99,106).

I.A.

STATEMENT OF RESEARCH PROBLEM
HRT-18 cells consist of heterogeneous cell types which differ in

BCV susceptibility.

Four HRT-18 cell clones were established by

limiting dilution in hopes of selecting cell types which were refractory
or varied in susceptibility to the virus.

To assess putative

differences between the clones, it was necessary to characterize their
susceptibility to BCV infection and the growth properties of each clone.
Both host cell-dependent factors and the strain of virus affect
coronavirus replication in culture (37,47).

The influence of the host

cell, virus strain, and trypsin modification on BCV cytopathic
expression was examined.
infectivity was explored.

Additionally, the effect of trypsin on BCV
Activation of cell-fusing activity of MHV is

dependent on cleavage of the E2 glycoprotein.
processing varies between cell types (37,117).

The extent of protein
Host cell-dependent

3
differences in the processing of structural proteins were suspected for
BCV and were examined in this study.

I.B.

OBJECTIVES
The following objectives were derived from the research problem.

1 - To characterize the HRT-18 clones
a - Determine the cytopathogenicity of BCV in each clone,
b - Characterize the clones based on morphology, growth kinetics,
plating efficiency, and growth in soft agar.
2 - To determine the effect of virus strain, host cell, and trypsin on
BCV-induced cytopathic expression and plaque formation.
3 - To assess the effect of trypsin on BCV infectivity.
4 - To analyze the polypeptide profiles of BCV propagated in different
cell types.
a - Assess differences in profiles,
b - Examine the effect of trypsin on profiles,
c - Correlate virus proteins to cell fusion.
The investigations designed to accomplish each objective were
written as individual manuscripts suitable for submission as journal
articles.
1.

They are entitled:

"Characterization of Specific Properties of HRT-18 Cell Clones:
Cell Morphology, Growth Kinetics, Plating Efficiencies, and
Expression of Bovine Coronavirus."

Submitted to In Vitro.

Co-authored by G.F. Amborski, M.J. Newman and J. Storz.
2.

"The Influence of the Host Cell, Virus Strain, and Trypsin
Modification on Bovine Coronavirus Cytopathic Expression and Plaque

4
Formation."

Submitted to Journal of Veterinary Medicine.

Co-authored by J. Storz.
3.

"The Influence of the Host Cell and Trypsin Treatment on Bovine
Coronavirus Infectivity".
Medicine.

4.

Submitted to Journal of Veterinary

Co-authored by H.R. Payne and J. Storz.

"The Effect of the Host Cell and Trypsin Treatment on the Structural
Proteins of Bovine Coronavirus Strain L9."
Virology.

Submitted to Archives of

Co-authored by K. Hussain, R.L. Schnorr, and J. Storz.

CHAPTER II. REVIEW OF PERTINENT LITERATURE
II.A.
II.A.I.

COMPARATIVE ASPECTS OF CORONAVIRUS PROPERTIES
Classification and Morphology

Coronaviruses are members of the family Coronaviridae, comprised of
the single genus Coronavirus.

Originally, this family was recognized

based on the unique morphology of the virus - spikes or peplomers formed
by surface glycoproteins extend from the virion, giving it the
appearance of a "corona" (47,125).

The family is now recognized for its

distinct physical, chemical, and antigenic properties (83).
Coronaviruses are positive-stranded RNA viruses.

The virions are

spherical to pleomorphic with a diameter of 80-220 nra.

These viruses

are enveloped with a lipoprotein membrane which is obtained as the virus
buds through intracellular membranes (47).

II.A.2.

Structural Proteins

The number of structural proteins comprising the virion of different
coronaviruses is shown in Table 1.1.

The best studied coronavirus is

mouse hepatitis virus (MHV) strain A59.

For many years this virus was

thought to consist of three structural proteins:

El (23 kilodaltons) -

the matrix glycoprotein, E2 (180 Kd) - the peplomeric glycoprotein, and
N (50 Kd) - a phosphoprotein forming the nucleocapsid (115).

Recently,

Sturman and coworkers (119) demonstrated that the 180 Kd protein
consists of a dimer of two 90 Kd polypeptides, separable by
hydroxyapatite chromatography and consisting of different peptides upon
limited protease digestion.

Robbins and coworkers (101) identified a

140 Kd protein from MHV virions and infected cells which is an RNA
binding protein.

This protein is reduceable to 50 Kd products, and is
5
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antigenically related to the nucleocapsid.

The protein is probably a

multimeric form of the nucleocapsid protein.
Six polypeptides comprise the MHV strain JHM virion.

A group of

three glycoproteins ranging in molecular weight from 97.5 Kd to 170 Kd
form the peplomers.

A 60.8 Kd protein most likely serves as

nucleocapsid, and a 22.7 Kd protein and a 24.8 Kd glycoprotein are
located in the lipid bilayer (128).
Diarrhea virus of infant mice (DVIM) is a newly isolated
coronavirus.

Sugiyama et al (120) have identified four structural

proteins associated with this virus consisting of three glycoproteins gp 180 Kd, gp 69 Kd, gp 25 Kd, and a 58 Kd protein. A 140 Kd
glycoprotein formed by two identical molecules of gp 69 is evident

under

non-reducing conditions.
The polypeptide profiles of coronaviruses associated with
respiratory and enteric infections of humans was determined.

HCV-229E

is a respiratory pathogen comprised of 3 major polypeptides:

a 180 Kd

gp, a 50 Kd phosphoprotein, and a 21-25 Kd gp family, as well as 3 minor
proteins of 107 Kd, 92 Kd, and 39 Kd (62).

The respiratory pathogen HCV

0C43 is made up of 4 major proteins - gp 190 Kd, gp 130 Kd (a disulfidelinked dimer of 65 Kd), pp 55 Kd, and a glycoprotein cluster at 26 Kd
(46).

The newly identified human enteric coronaviruses (HECV) 24 and 35

show major protein bands at 62 Kd, 60 Kd, 34 Kd, and 32 Kd and 5 minor
bands ranging from 56-110 Kd (5).

Human enteric coronavirus 14 consists

of 5 major proteins with molecular weights within the range of 190-23 Kd

(100 ).
Of particular interest is the polypeptide composition of bovine
coronaviruses.

Discrepancies exist about the number of structural
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proteins forming this virus, indicating that virus strain, cultural
conditions, and/or purification schemes may affect the number of protein
bands obtained by polyacrylamide gel electrophoresis.

In 1979 Hajer and

Storz (42) reported 7-10 structural proteins for BCV strain LY-138, a
field isolate purified from diarrhea fluid.

These proteins included gp

110, gp 100, p 82, p 70, gp 53, gp 45, and p 36.

Williams and Storz

(133) identified two forms of BCV strain L9 from isopycnic CsCl
gradients.
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These virions had densities of 1.223 and 1.255 g/cm and

exhibited different polypeptides profiles.

Common to both types were

polypeptides of 53 Kd, 47 Kd, 35 Kd, and a 22-26 Kd pentacluster.

Light

virions had additional bands at 182 Kd, 109 Kd, and 20 Kd, while dense
virions had unique proteins of 172 Kd, 95 Kd, 21 Kd, and 15 Kd.
Other investigators reported fewer proteins associated with the
virion of BCV-L9.
the virus:

King and Brian (63) described 5 proteins comprising

glycoprotein 140 which is a disulfide-linked dimer of 65 Kd

subunits, gps 120, 100, and 26 Kd and a 52 Kd phosphoprotein.

Hogue,

King and Brian (46) identified a 190 Kd glycoprotein which was normally
present as 120 Kd and 100 Kd subunits.

Using pronase and bromelain

digestion, King and coworkers (64) determined that gp 140, 120, and 100
are surface proteins with gp 140 serving as viral hemagglutinin.

Using

monoclonal antibody reactivity to BCV G110 surface proteins, Vautherot
and other investigators (126) showed that a 105 Kd glycoprotein was
important in virus-cell interactions and hemagglutination.

The profiles

of a wild-type BCV isolate (BECV-WS) and a cell-adapted strain
(BECV-F15) were compared by Laporte and Babulesco (71).

They found very

similar protein compositions for the two viruses with polypeptide bands
at 125 Kd, 65 Kd, 50 Kd (major protein), 45 Kd, 36 Kd, and 28 Kd.
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The structural proteins associated with other mammalian
coronaviruses was evaluated.

The composition of a rabbit enteric

coronavirus was examined by Descoteaux and coworkers (31).

They found 8

structural proteins - 7 associated with the envelope with molecular
weights ranging from 100 Kd-34 Kd and a single nucleocapsid protein of
54 Kd.
The porcine coronavirus of transmissible gastroenteritis (TGEV)
reportedly consists of 4 major proteins - gp 200 (surface protein), gp
30, gp 28.5, and vp 50.
the 200 Kd protein (41).

Two minor proteins of 105 and 80.5 Kd comprise
Hemagglutinating encephalomyelitis virus

(HEV), a cause of porcine vomiting and wasting disease, is composed of 8
structural proteins with molecular weights ranging from 180-31 Kd. The
surface projections are formed by gps 180, 130, and 75, with gp 76
serving as viral hemagglutinin.
membrane associated.

Glycoproteins 31 Kd and 32 Kd are

A 64 Kd protein is the only nonglycosylated

protein (17).
Garwes (40) determined the polypeptide structure of canine
coronavirus, an enteric pathogen antigenically and structurally related
to TGEV.

The virus has 4 structural proteins - gp 204, p 50, gp 32, and

gp 22.
Coronaviruses causing feline peritonitis and gastroenteritis have
been identified.

Boyle and investigators (9) demonstrated three major

proteins comprising these viruses.

A 45 Kd protein forms the

nucleocapsid; a 210 Kd protein is the peplomeric protein; and a 27-33 Kd
cluster is the matrix protein.

A minor protein of 42 Kd is also

associated with feline coronavirus.

9
Infectious bronchitis virus (IBV), an avian coronavirus, was once
considered to be more complex than mammalian coronaviruses with reports
of 7-16 structural proteins (73,111).

However, MacNaughton and Madge

(78) discovered that additional protein bands on SDS-PAGE gels were a
result of harsh treatment during virus preparation.
reported 3 major proteins for IBV.
which is cleaved to

Cavanagh (18,19,20)

Sq is a surface protein precursor

(gp 90 Kd) and S£ (gp 84 Kd).

The matrix protein

is composed of glycosylation isomers of 23-34 Kd, and N (nucleocapsid)
has a molecular weight of 50-54 Kd.
revealed that

Urea treatment of IBV virions

is responsible for viral infectivity and

hemagglutinating activity, but not attachment to susceptible cells.
This molecule also elicits antibodies which cause virus neutralization
and hemagglutination inhibition (21,22).

II.A.3.

Non-structural Proteins

Very little is known about the structure and function of the
coronavirus non-structural proteins.

Most likely they function in

regulation of replication and transcription of the virus.

Messenger RNA

1, a genome length transcript, codes for the 200 Kd viral RNA-dependent
RNA polymerase.

Two other non-structural proteins of 30 Kd and 14-17

Kd, coded for by mRNAs 2 and 5, respectively, have been identified, but
the function of these is unknown (66,80).

Budzilowicz and Weiss (12)

sequenced the nucleotides of MHV A59 mRNA 5 - a nonstructural gene.

Two

open reading frames (ORF) coding for two non-structural proteins were
identified.

One ORF codes for a 13 Kd protein which is rich in basic

amino acids and possibly serves as an RNA binding protein.

The other

ORF codes for a 9.6 Kd protein containing a long stretch of hydrophobic
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amino acids.

This protein may function in the association of viral

polymerase complexes with membranes.

II.A.4.

The Glycosylation Process

The number and sizes of the glycoproteins associated with
coronaviruses is different, but those associated with MHV are well
characterized according to structure and function.

A 20-30 Kd

transmembrane glycoprotein (El) forms the matrix of the MHV virion.
Using dog pancreatic microsomes, Rottier and coworkers (103) determined
that the protein is primarily located within the membrane with only
small portions of the amine and carboxy termini protruding from the
membrane.

The protein has no cleavable membrane insertion sequence.

Instead, three hydrophobic regions of approximately 20 amino acids each
are located within the protein at positions 27-46, 57-77, and 82-102
(56).

The hydrophobic sequence located closest to the carboxy terminus

serves as the signal sequence.

This internal signal sequence requires

signal recognition particle for proper membrane insertion (102).
Glycosylation of El of murine and bovine coronaviruses is resistant to
tunicamycin, indicating that sugar residues are linked via O-glycosidic
bonds to serine or threonine residues with no involvement of
dolichol-linked N-acetylglucosamine intermediates found in N-linked
glycosylation (50,95).

However, N-linked oligosaccharides are found on

the El glycoprotein of IBV (112).

Glycosylation of El does not occur in

the rough endoplasmic reticulum, rather, the protein is most likely
glycosylated as completed virions pass through the Golgi (103).

Studies

indicate that El probably directs budding of the virion through
intracellular membranes.

For example, Tooze et al (123) demonstrated
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the localization of El on membranes of the endoplasmic reticulum and
Golgi, where budding occurs.

Additionally, tunicamycin-treated cells

which lacked E2 showed normal budding (49).

El also interacts with the

nucleocapsid, probably binding N to the viral envelope as it buds (118).
The number of glycoproteins comprising the coronavirus peplomer
depends on the strain of virus.

The peplomeric glycoprotein of MHV-A59

(E2) has a molecular weight of 180 Kd and is comprised of two 90 Kd
species,

90A and 90B, which are noncovalently associated and are

separable by host protease or by trypsin cleavage.

90A is acylated with

palmitic acid and is probably associated with the lipid bilayer.
not acylated (119).

90B is

The native 180 Kd molecule has one trypsin cleavage

site, and intrachain disulfide bonding contributes to its conformation
(115,116).

Unlike the matrix glycoprotein, glycosylation of E2 is

tunicamycin sensitive, involving en bloc transfer of oligosaccharides
from a dolichol-linked N-acetylglucosaraine intermediate.

The resulting

linkage is N-glycosidic and occurs between N-acetylglucosamine and
asparagine (95).

This molecule can migrate to the plasma membrane

rather than remaining localized at intracellular membranes (117).
Several biological activities are directly attributed to the peplomer.
This molecule is responsible for binding the virus to cell receptors.
For example, decreased binding of virus to the cell occurred with virus
which lacked peplomers (50).

Monoclonal antibody directed against gp

105 of BCV neutralized the virus and inhibited hemagglutination (126).
Limited enzymatic digestion with pronase or urea demonstrated
hemagglutinating activity of surface proteins of bovine and avian
coronaviruses (21,64).

Immunologically, E2 is responsible for induction

of neutralizing antibody to the virus, and its presence on the cell
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surface elicits a cell-mediated response (26,43).
of MHV is attributed to E2.

Cell-fusing activity

Using monoclonal antibody against E2 of

MHV-JHM, Collins and others (26) inhibited cell fusion of L241 cells.
Tunicamycin treatment of MHV-A59-infected 17C11 cells blocked
glycosylation of E2 and prevented cell fusion (50).

With MHV-A59, cell

fusion is a result of cleavage of inactive 180 Kd protein into its 90 Kd
subunits (37,119).

II.A.5.

Antigenic Properties

Antigenically', coronaviruses can be divided into two main groups:
- avian strains and 2 - mammalian strains.
further subdivided (Table II.2) (77).

The mammalian strains can be

Antigenic relatedness between

strains was for the most part determined by immunofluorescence studies.
Recent studies have focused on the cross reactivity of individual
proteins.

For example, Hogue et al (46) used antiserum against BCV

structural proteins to assess cross reactivity of BCV-L9, MHV-A59, and
HCV-0C43.

HCV-OC43 was found to have four proteins which are

antigenically homologous to BCV, while MHV-A59 had three antigenicallyrelated proteins.

Monoclonal antibodies were used by Snyder and

Marquardt (108) to assess the antigenic relationships of IBV serotypes
and Fleming et al (36) to assess antigenic relationships of murine
coronaviruses.

II.B.
II.B.l.

UNIQUE FEATURES OF CORONAVIRUS REPLICATION
Attachment and Penetration

Attachment of coronaviruses to the receptors of susceptible cells
occurs via the peplomers (21,50,64,126).
receptor is unknown.

1

The nature of the coronavirus

Boyle, Weismiller, and Holmes are attempting to

13
clone the MHV receptor gene (Mhv-1) from susceptible mice (8).

The

internalization process used by this virus is undetermined, but must
occur either by fusion of the viral envelope to the plasma membrane or
by endocytosis followed by fusion with an endocytic vesicle (47).

II.B.2.

Coronavirus Genetic System and Its Replication

The coronavirus genome consists of positive-stranded RNA which is
single-stranded, linear, and unsegmented.

The genome is capped,

polyadenylated, and infectious, making it capable of serving as
messenger.

The RNA has a molecular weight of 5.5 x 10^ daltons,

consisting of 15,000-20,000 bases (47,110).
Following internalization and uncoating, genomic RNA serves as
messenger for transcription of RNA-dependent RNA polymerase.

This

polymerase transcribes the genome into a full-length, negative-stranded
replicative form, which serves as a template for mRNA transcription and
synthesis of genomic RNA (83).

Different polymerases are used for

synthesis of mRNA and genome RNA.

Replication of genomic RNA from the

replicative form proceeds by a discontinuous or "stop and go" mechanism.
This mechanism was suggested by the discovery of many small leadercontaining RNA species whose size corresponded to lengths between the 5'
end and probable hairpin loops of genome RNA.
were thought to be pausing intermediates (66).

These small RNA species
The first demonstration

of recombination between the genomes of murine coronaviruses A59 and JHM
was reported in 1985 (68).

Makino and coworkers (81) have since

demonstrated high frequency recombination between different strains of
murine viruses.

Since the genome of coronaviruses is non-segmented,

this finding suggests that segmented RNA intermediates might be
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generated and supports the discontinuous model.

The discontinuous mode

of replication has also been shown to occur in QB, MS2, and T2 phages
(61,87).

II.B.3.

Transcription and mRNA Properties

Coronavirus mRNA consists of a "nested set" of six subgenomic and 1
genome-sized mRNA molecules.

The mRNAs share common 3' ends, but differ

in length toward the 5' end.

The mRNAs are functional - each is capped,

polyadenylated, and associated with polysomes.

One protein is coded for

by each mRNA - the translated sequence isfound in

the 5' region not

contained in the next smaller mRNA species.The protein product
translated from each mRNA has been defined as follows for MHV and TGEV:
mRNA 1 - genome length - polymerase
mRNA 2 - non-structural protein
mRNA 3 - E2
mRNA 4 - non-structural protein
mRNA 5 - non-structural protein
mRNA 6 - El
mRNA 7 - N
These mRNAs are produced in non-equimolar amounts, but in constant
proportions.

The 5' ends of the genome and all mRNAs are identical,

consisting of a cap structure and

50-70 identical nucleotides

(58,64,69,110).
The fact that the leader and translated sequences of mRNAs are
discontinuous on the genome has led to speculation about the mechanism
of transcription.

UV transcription mapping showed that target sizes for

UV inactivation were identical to the physical sizes of mRNAs.
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Therefore, transcription does not involve processing of larger RNAs
(59).

In 1983 Spaan and investigators (110) proposed a polymerase-jump

mechanism involving synthesis of short RNA transcripts from the 3' end
of the negative-stranded RNA and translocation of the polymerase-leader
complex to internal positions on the template.

More recently this

mechanism has been termed "leader-primed transcription."

Specifically,

this model involves the transcription of leader RNA from the 3' end of
negative-stranded template which dissociates from the template.

This

free leader RNA binds to intragenic regions with homologous sequences on
the RNA template.

Leader RNA is cleaved at mismatched points generating

a primer for initiation of mRNA transcription.

Therefore, the

leader-body fusion site varies for each mRNA species, according to the
location of mismatched nucleotides.

A regulatory mechanism for

controlling the synthesis of RNA in infected cells may be the number of
homologous nucleotides found at the intragenic sites preceding each mRNA

(66).
"Leader-primed transcription" is supported by several studies,

a)

Leader RNAs of 50-90 nucleotides have been found in the cytoplasm of MHV
cells (4) b) Budzilowicz et al (13) found three intragenic regions of
MHV genome RNA with sequences common to the 3' end of mRNA leader
sequences.

These sequences may contain a binding site for hybridization

of leader RNA to negative-stranded viral RNA at the beginning of each
gene to prime synthesis,

c) Leader RNAs separate from the RNA template,

and ts mutants which produce leader RNA but not mRNA indicate that
transcription of leader and mRNA are separate events (67).

d) A high

frequency of reassortment of leader sequences between coinfecting murine
coronaviruses indicates a potential trans-acting property of leader RNA
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(82).

Additionally, evidence for leader-primed transcription was shown

with avian coronaviruses (11).

II.B.4.

Role of Cellular Organelles in Assembly

Assembly of mammalian coronaviruses occurs in the cytoplasm of
infected cells.

There is no involvement of the cell nucleus.

Tooze and

coworkers (123) examined the replication and assembly of MHV in Saccells using immunofluorescent analyses and electron microscopy.

The
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uptake of [ H] uridine in actinomycin D-treated cells revealed the
synthesis of viral RNA within 4-5 hours post infection.

Synthesis of

the viral RNA occurs in the cytoplasm of infected cells (131).
Immunofluorescent analyses using polyclonal antibodies against disrupted
whole virions and viral nucleocapsid (N) protein detected the presence
of N within 4 hours post infection.

The N protein is translated from

the most abundant viral mRNA on free polysomes (104,123).

N protein and

newly synthesized genomic RNA associate in the cytoplasm to form a
helical ribonucleoprotein.

Translation of E2 occurred on the rough

endoplasmic reticulum within 6 hours post infection.

E2 is

cotranslationally glycosylated via N-glycosidic linkages at asparagine
residues, and core oligosaccharides are trimmed as the molecule passes
through the Golgi.
membrane (117).

This protein is capable of migration to the plasma

Translation of El was detected by immunofluorescence

within 6 hours post infection in the rough endoplasmic reticulum.

Using

its internal insertion signal, the molecule is inserted into the
membrane of the rough endoplasmic reticulum and transported to a smooth
membrane perinuclear compartment where it is incorporated into virions.
Intact virions are transported to the Golgi, where O-glycosylation of El
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occurs (56,103,123).

Glycosylation of this protein does not involve the

dolichol-linked N-acetylglucosamine intermediate.

Rather, sugar

moieties are linked at serine or threonine residues (94).
transported to the plasma membrane.

El is not

The protein is confined to the

intracellular membranes of the rough endoplasmic reticulum and Golgi,
ant it only reaches the cell surface as a part of the mature virion.
Budding occurs at sites where El accumulates, and is initiated when
ribonucleoprotein recognizes the C-terminus of El projecting from
intracytoplasmic membranes.

Namely, budding in the smooth perinuclear

vesicles and tubules located between the rough endoplasmic reticulum and
Golgi was detected by EM within 6-7 hours post infection.

At late

stages of infection, El accumulated in the membranes of the rough
endoplasmic reticulum, and budding occurred there (123).

Doughri and

coworkers (33) demonstrated that release of mature virions from the cell
is a result of fusion of post-Golgi vesicles with the plasma membrane.
This mechanism of release probably utilizes the host secretory
apparatus.
Unlike mammalian coronaviruses, the replication of IBV is impaired
in enucleated, UV irradiated, or a-amanitin treated cells, indicating
the involvement of the cell nucleus and host transcriptional factors in
virus replication (34).

In addition, the El glycoprotein of IBV is

glycosylated through N-glycosidic linkages (112).

These differences

between mammalian and avian coronaviruses suggest that the replication
strategy of the two virus groups are different.
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II.C.

EVIDENCE FOR PROCESSING OF CORONAVIRUS PROTEINS AND ACTIVATION OF
CELL FUSION

In some cell culture systems coronaviruses are able to induce cell
fusion.

The relationship between induction of cell fusion and cleavage

of viral proteins is of particular interest.

The prototype virus, MHV,

has provided much of the current knowledge in this area of study.
Using four different murine cell lines, Frana and coworkers (37),
demonstrated that processing of the 180 Kd E2 glycoprotein of MHV-A59 to
its 90 Kd subunits was host dependent.

Different cells cleaved the

precursor molecule to different extents and the cell-fusing activity of
the virus correlated in part to the degree of proteolytic cleavage.

For

example, virions obtained from Sac- cells contained E2 which was
completely cleaved to the 90 Kd form.

These virions induced rapid cell

fusion in L2 cells without requiring virus replication.

In contrast,

virions obtained from 17C11 cells had partially cleaved E2 and required
trypsin for activation of rapid cell fusion.
The role of protease in MHV-induced cell fusion was also studied by
Yoshikura and Tejima (135).

Using a cold-sensitive plaque mutant, they

showed that treatment of infected cells with trypsin enabled the mutant
virus to form plaques consisting of fused cells on otherwise resistant
cells, and allowed a virus which usually producedplaques consisting

of

dead cells to form fusion plaques.
Storz and coworkers (114) found that cell fusion of BCV strain L9
was enhanced in the presence of trypsin when the virus was grown in
bovine fetal brain or bovine fetal thyroid

cells. Cell fusion occurred

only minimally in thyroid cells and not at

all inbrain cells in the
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absence of trypsin, but fusion was apparent within 12 to 18 h post
infection when trypsin was present.
The protein(s) responsible for cell fusion are under investigation.
In 1982, the 170 Kd glycoprotein of MHV-JHM was identified as the viral
glycoprotein responsible for attachment and cell fusion.

Sturraan and

investigators (119) demonstrated that the 180 Kd E2 glycoprotein of
MHV-A59 could be cleaved by trypsin or cellular proteases to two
different 90 Kd products, 90A and B, and consequently activate cellfusing activity of the virions.

It is unknown which of the two species

mediates cell fusion, but the amino acid sequence at the new terminal
domains of the proteins is currently under investigation.
Electron microscopy of negatively-stained particles revealed that
BCV virions with shortened surface projections were produced in
trypsin-treated cultures (114).

Williams and Storz (133) resolved two

BCV-L9 phenotypes in linear CsCl gradients.

These had densities of
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1.223 and 1.255 g/cm , but the relative proportion of dense virions
increased in the presence of trypsin. The two virus phenotypes contained
common polypeptides of 53, 47, 35, and 22-26 Kd pentacluster.

Light

virions contained additional proteins of 182, 109, and 20 Kd.
Trypsin-dependent bands of 172, 95, 21, and 15 Kd were present in dense
virions.

The protein(s) responsible for BCV-induced cell fusion are

undetermined.
The effect of trypsin on plaque development of BCV-L9 in bovine
fetal brain and bovine fetal thyroid cells was examined (114).

Plaque

diameter was increased more than 5-fold when the enzyme was present in
the overlay, and plaques were less turbid and more distinct.

Plaque
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formation by many IBV strains in chicken embryo cell cultures required
the presence of trypsin (97).
Toth (124) treated BCV-infected bovine embryonic lung cells with
increasing concentrations of trypsin.

He found that the viral

infectivity, as well as the rate of replication was enhanced by trypsin
in direct correlation with increases in trypsin concentration.
Indirectly, protease was shown to play a role in the production of
human coronavirus.

Appleyard and Tisdale (2) treated HCV strain

229E-infected MRC-C cells with the protease inhibitor leupeptin.

They

found that the drug prevented multiplication of the virus if added
within 2 h of infection, suggesting action at an early stage of
replication.

Frana and coworkers (37) also found that leupeptin delayed

the onset of fusion in MHV-infected L2 cells by 4-6 hours and reduced
the size of giant cells.

II.D.

CYTOCIDAL ACTION OF CORONAVIRUSES IN BOVINE GASTROENTERITIS

Gastroenteritis is a major cause of morbidity and mortality in
newborn animals.

Numerous bacterial and viral agents cause this

syndrome, but coronaviruses are a major cause of enteric infections in
neonatal bovines.

The high morbidity and mortality rate associated with

the disease makes it one of economic significance in the cattle
industries (7).

Chronic shedding of coronavirus antigen-antibody

complexes was demonstrated by ELISA in clinically normal cows, with 85
of 121 cows (70%) responding positively.

Shedding of the virus was

found to be seasonal, with detectable virus occurring during the winter
months (November to March), while no virus was detectable during summer
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months (July to September).

Subclinical infections of adult cattle may

serve as a source of infection for the neonate (27,29,30).
The high stability of the virus contributes to spread of infection,
which occurs by ingestion of the agent.

The proximal part of the small

intestine is the first site of infection, followed by progression to the
jejunum, ileum, and colon.

The virus primarily attacks the

differentiated absorptive epithelial cells and goblet cells of the
villi, but there is some involvement of undifferentiated cells of the
Crypts of Lieberkuhn and fibroblasts and endothelial cells of small
blood capillaries of the lamina propria mucosae.

Histologically, the

most severe cytopathic changes occur in the proximal jejunum of the
small intestine.

Villi become broadened and shortened, fusion between

adjacent villi occurs, with some denuding of the villi.

Absorptive

epithelial cells may become vacuolated and necrotic; goblet cells are
reduced in number; and crypt epithelium becomes hyperplastic.

The

lamina propria mucosae may be edematous and infiltrated with mononuclear
and polymorphonuclear cells.

Distention of the smooth and rough

endoplasmic reticulum and vesiculation of the Golgi occurs, and
mitochondria swell, dilate, and decrease in number.

Severe degeneration

and necrosis of cellular organelles occurs, including ribsome depletion,
distortion of mitochondrial cristae, and vacuolation of the cytoplasm.
Fragmentation of the plasmalemma is apparent, and nuclei become pyknotic
and lyse.

Viral inclusions are evident in the cytoplasm.

As a result of the cytocidal action of bovine coronavirus in the
intestine, a profuse, watery diarrhea develops.

Fluid loss is due to an

osmotic imbalance caused by undigested lactose in the lumen - a
consequence of the loss of cells possessing disaccharidases and
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replacement of these mature cells by undifferentiated cells retaining
secretory function.

With the loss of mature enterocytes there is a

decrease in the glucose,, sodium carrier and (Na+-K+) ATPase causing the
loss of sodium, potassium, chloride, bicarbonate, and water.

Depletion

of bicarbonate causes acidosis which in turn contributes to K+-H+ ion
exchange across cell membranes with a net loss of potassium from cells.
Calves become hypoglycemic with inhibited gluconeogenesis and increased
glycolysis.

II.E.

Death is often the result of severe diarrhea (3,32).

HOST CELL RANGE OF CORONAVIRUSES.

Most coronaviruses are highly species specific, causing disease only
in the species from which the virus was isolated, and demonstrate a
marked degree of tissue tropism.

For example, IBV is restricted to

diseases of the respiratory tract, the site of virus replication.

TGEV

and bovine, canine, and turkey coronavirus replicate in the intestinal
epithelum, causing enteric infections.

The human coronaviruses HCV-229E

and HCV-OC43 cause respiratory infections, and the human enteric
coronavirus (HECV) is a cause of infantile enteritis (5,76,100).
Coronaviruses were isolated from the brains of patients with multiple
sclerosis (15,109).

Murine coronaviruses cause respiratory, enteric,

and neurological diseases in mice (47).

Two cases of cross species

infection have been reported - a natural infection of dogs by TGEV, and
an accidental transmission of BCV to man (72,113,127).
Typically, coronaviruses do not replicate well in cell culture,
usually requiring organ cultures or differentiated cells from the host
species (47).

Some strains of BCV and HECV do not replicate in cultured

cells and have been identified by electron microscopy of diarrhea fluids
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(5, 100, and Storz, personal communication).

Mebus and coworkers (84)

adapted BCV-L9 to culture using primary cultures of bovine fetal kidney
cells.

Successful culture systems using established cell lines have

been developed for several coronaviruses.

Avian and bovine

coronaviruses replicate well in Vero cell lines (1,121).

The

adenocarcinoma cell line, HRT-18, established by Tompkins et al (122),
is used for propagation of BCV (63,133).

Enhancement of the replication

of coronavirus in culture was accomplished by including trypsin in the
culture medium (37,97,114,124,133,135).
Depending on the host cell, coronavirus infections may range from
highly cytocidal to inapparent (47).
fuse into syncytia or lyse.

In cytocidal infections cells may

In contrast, feline, murine, human, and

avian coronaviruses are able to establish persistent infections leading
to carrier cultures in some cell culture systems (47,48,23,75).

The

mechanism of resistance of cells to coronavirus infection is mostly
unknown.

Boyle et al (8) demonstrated that genetic resistance of the

inbred mouse strain SJL/J to MHV infection is due to the lack of a
receptor which is present on susceptible mice.

II.F.

PROTEOLYTIC ACTIVATION OF THE ENVELOPE PROTEINS OF
PARAMYXOVIRUSES AND ORTHOMYXOVIRUSES

Proteolytic activation of infectivity and cell fusion was first
observed in paramyxoviruses.

Hosaka in 1967 (134) and Young and Ash in

1970 (136) reported a decrease in the cell-fusing activity of Sendai
virus and Newcastle disease virus following a single passage in tissue
culture.

Classically, Homma (51,52) and Homma and Tamagawa (54) noted

that Sendai virus propagated in chicken embryos was infectious and
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induced cell fusion in L cells, and was hemolytic to guinea pig
erthrocytes.

After a single round of replication in L cells, Sendai

virus was noninfectious, did not induce fusion, and was nonhemolytic.
Trypsin treatment of purified Sendai virus restored all three biological
activities.

Cell-fusing activity, hemolysis, and infectivity are a

result of cleavage of an inactive precursor molecule, Fo, to its active
subunits, FI and F2, by host cell proteases or by trypsin
(51-54,93,99,106).

Since its identification in paramyxoviruses,

proteolytic activation of infectivity was identified in other viruses.
Orthomyxoviruses, rotaviruses, and coronaviruses require cleavage of
precursor proteins for activation of viral infectivity and/or cell
fusing activity (35,37,39,97,114,124,133,135).

II.F.l.

Paramyxoviruses.

Two surface glycoproteins are found on paramyxoviruses hemagglutinin - neuraminidase (HN) and fusion (F).

HN is a 72 Kd

protein which is responsible for adsorption of the virus to host cell
neuraminic acid receptors and cleavage of viral neuraminic acid residues
to prevent self aggregation during release from the cell.
is a dimer of identical disulfide-linked molecules.

The protein

Studies with

Newcastle disease virus show that inactive HNo is cleaved to yield the
active HN molecule.

Failure to cleave the precursor molecule results in

noninfectious virus (93).
The 65 Kd F protein allows penetration into the host cell by lysing
the host cell membrane and causing fusion of the viral envelope and cell
membrane.

The nucleocapsid can then be released into the cell
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cytoplasm.

The presence of F protein on the surface of infected cells

also induces lysis of membranes and cell fusion (24).
An inactive precursor polypeptide, Fo, is initially produced in
infected cells. Fo is cleaved by host cell protease to FI and F2
subunits (52 Kd and 13 Kd, respectively).
linked to form the F protein.

These subunits are disulfide

FI contains the carboxy terminus of the

precursor molecule and is anchored in the viral envelope, and F2
contains the original N terminus.

Cleavage of Fo reveals a new N

terminus on FI that is very hydrophobic and contains 18 highly conserved
amino acids (25).

The hydrophobic sequence is important in fusion of

virus-cell membranes and infected cell-uninfected cell membranes.

II.F.l.

Orthomyxoviruses

Orthomyxoviruses have two surface glycoproteins - hemagglutinin (HA)
and neuraminidase (NA).

HA functions in attachment of the virus to

sialic acid-containing glycoproteins on the cell surface and in
penetration into the cell during initial stages of infection.
of influenza are attributed mainly to variation in HA protein.

Outbreaks
The

function of NA is unclear, but its enzymatic activity may prevent
aggregation of virus particles and promote release from infected cells
by removing receptors from HA, itself, and the infected cell surface
(92,98).

The NA protein consists of a single polypeptide which

undergoes no post-translational processing.
The HA protein is synthesized as a single polypeptide of 75 to 80 Kd
(28).

Following post-translational cleavage of the N terminal signal

sequence and removal of one or more intervening amino acid residues, two
polypeptides result.

HA1 and HA2 (36 and 27 Kd, respectively) are
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linked by a single disulfide bond, and a trimer of these molecules
comprises the HA spike (92).
Garten and coworkers (39) identified the amino acid sequence at the
cleavage site of the HA protein.

In the active form, the C terminus of

HA1 has the sequence gln-ser, and the N terminus of HA2 has the sequence
gly-leu-phe-gly-ala-ile.

Activation of the protein is accompanied by an

acidic shift in the isoelectric point of HA, indicating that an
intervening arginine residue is removed from the cleavage site.

Two

proteases are involved in the activation of HA: trypsin or a
trypsin-like endoprotease of cellular origin to cleave the arg-gly bond;
and an exopeptidase of the carboxypeptidase B type to remove the
arginine.

In vitro cleavage of HA in the presence of purified virus and

trypsin resulted in removal of the arginine residue.

Therefore, this

enzyme is either a host component tightly associated with the virus
particle or a virus-encoded protein.

Interestingly, cleavage by

chymotrypsin or thermolysin only slightly shifts the cleavage site, but
these do not activate HA.

Consequently, activation of HA involves a

highly specific cleavage site.

Cleavage of the precursor molecule into

HA1 and HA2 is required for viral infectivity.

Orthomyxoviruses exhibit

low infectivity if grown in cells lacking the proper proteases, but the
virus can be activated by treatment with trypsin (92).

II.G.

PROPERTIES OF NEWLY RECOGNIZED GASTROENTERITIS AGENTS:

THE

TOROVIRUSES
The proposed family Toroviridae is composed of two recognized
gastroenteritis agents - Berne virus (BEV) and Breda virus (BRV).

Berne

virus was isolated in 1972 from a rectal swab of a diarrheic horse in
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Berne, Switzerland (130).

Breda virus was obtained during an acute

epizootic of neonatal calf diarrhea in Breda, Iowa in 1982 (134).

A

morphologically similar and antigenically related virus was detected in
cattle from Lyon, France and named Lyon 4 virus (89,90).

Virus

particles resembling BEV and BRV were isolated from humans with
gastroenteritis (6,55).
Morphologically, toroviruses are pleomorphic particles measuring
120-140 nm, and were described as spherical, oval, elongated, or
kidney-shaped particles.

These viruses are enveloped and surrounded by

drumstick-shaped peplomers of 20 nm in length.
elongated, tubular, and probably helical.

The nucleocapsid is

The name "Toroviridae" was

derived from the Latin torus = a doughnut shaped ring.

The RNA genome

of these viruses is single-stranded with a molecular weight of 5.7 x 10^
d.

The genome is polyadenylated and infectious and probably of positive

polarity (130,134).
BEV and BRV are structurally similar, consisting of proteins in the
molecular weight range 75-100, 37, 22, and 20 Kd.

The 20 and 37 Kd

proteins of BEV are phosphorylated, and the 20 Kd species is the most
prevalent protein.

This protein has RNA binding properties and

represents the major capsid protein.

The 22 Kd protein probably serves

as a constituent of the envelope, while the phosphorylated 37 Kd species
may be a matrix protein.

The 75-100 Kd glycoproteins are tunicamycin

sensitive, probably containing N-linked oligosaccharides (129).
Toroviruses are extremely UV sensitive, but withstand pH extremes of
2.5 to 10.3.
(134).

Infection of susceptible hosts is probably by ingestion

BRV was shown by immunofluorescence and electron microscopy to

replicate in vivo in epithelial cells of the colon, the caudal part of
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the jejunum, and the ileum.

Crypt cells and villous cells of the ileum

and jejunum are infected, as are most cells of the large intestine
(129,134).

BEV replicates in cell culture in equine cells, but attempts

to propagate the virus in other mammalian cells were unsuccessful (130).
BRV and human toroviruses do not replicate in any culture system
attempted so far (6).
The replication of BEV was inhibited by treatment of infected cells
with actinomycin D,a -amanitin, and UV irradiation, indicating some
nuclear involvement in the replication of BEV.

Within 6 hours post

infection virus-specific proteins were evident in BEV infected equine
dermal cells.

A glycosylated, tunicamycin-sensitive species of 200 Kd

was detected which was shown to be a precursor of the 75-100 Kd protein.
Six or seven subgenomic and 1 genome-sized RNA species were extracted
from BEV-infected equine dermal cells.
and served as messenger.

These RNAs were polyadenylated

Tubular structures representing nucleocapsid

were detected in the cytoplasm and nucleus of infected cells.
Assembly of the virions involves budding of a preformed rigid
nucleocapsid through intracytoplasraic membranes.

Budding occurs

predominantly through the Golgi and to a lesser extent through the rough
endoplasmic reticulum.

Nucleocapsid attaches to the membrane and buds

through the membrane, apparently acquiring its diameter and electron
density.

Enveloped, rod-shaped virus is found in the lumen of the

cytoplasmic cisternae.

Virus is released after virus-containing

vesicles merge with the plasma membrane.

The morphology of the virus

changes from rod-like to the torus form during transmission from the
intravesicular to the extracellular state (129).
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The morphology, genetics, and replication of toroviruses closely
resemble coronaviruses.

Both viruses replicate in the intestinal

epithelium, causing gastroenteritis.

The identification of these

disease agents has obvious implications from the standpoint of
prevention or diagnosis of gastroenteritis infections.

Further study of

toroviruses on the molecular level is necessary to fully understand the
replication of the viruses and their major differences from
coronaviruses.

TABLE II.1

Numbers of Structural Proteins of Various Coronaviruses

Virus

Source

No. Proteins

Reference

Mouse Hepatitis virus

17C11, Sac-, L2 cells

5-6

(101,119,128)

Diarrhea virus of infant mice

DBT cells

4

(120)

Human coronavirus-229E

mrc5

6

(62)

Human coronavirus-OC43

HRT-18 cells

4

(46)

Human enteric coronavirus 24 and 25

diarrheic fluid

9

(5)

Human enteric coronavirus 14

human fetal intestinal organs

5

(100)

Bovine enteropathogenic coronavirus

diarrheic fluid, HRT-18 cells

7-10

(42,133)

BEK-1 cells, HRT-18 cells

5-6

(46,63,64,71,126)

Rabbit enteric coronavirus

diarrheic fluid

8

(31)

Transmissible gastroenteritis virus

primary pig kidney cells

4

(41)

Hemagglutinating encephalomyelitis

primary pig kidney cells

8

(17)

Canine coronavirus

dog kidney cells

4

(40)

Feline coronavirus

fetal cat whole fetus cells

4

(9)

Infectious bronchitis virus

chorioallantoic membrane of

3

(18,19,20)

virus

de-embryonated chicken eggs
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TABLE II.2.

Antigenic Groups of Coronaviruses Determined by

Immunofluorescence Analysis

Group 1

Group 2

Avian

Mammalian
Subgroup 1

Subgroup 2

Human Coronavirus-0C43

Human Coronavirus-229E

Bovine Coronavirus

Transmissible Gastroenteritis

Mouse Hepatitis Virus
Haramagglutinating encephalomyelitis Virus
Rat Coronavirus
Sialodacryoadenitis Virus
Diarrhea Virus of Infant Mice
Human Enteric Coronavirus

Virus
Feline Infectious Peritonitis
Virus
Canine Coronavirus

CHAPTER III.

CHARACTERIZATION OF SPECIFIC PROPERTIES OF HRT-18 CELL
CLONES:

CELL MORPHOLOGY, GROWTH PROPERTIES, PLATING

EFFICIENCIES, AND EXPRESSION OF BOVINE CORONAVIRUS
III.A.

INTRODUCTION

Human rectal tumor-18 (HRT-18) cells are used routinely for the
propagation of bovine coronavirus (46,63,64,133).

Turbid plaques

containing some apparently normal cells were produced by BCV-L9 in
HRT-18 cells.

This observation indicated that the HRT-18 cell

population is heterogeneous, consisting of subpopulations of cells which
may differ in susceptibility to infection or in production of infectious
virus.

In hopes of isolating cell types that were either refractory or

highly susceptible to BCV infection, HRT-18 cells were cloned by
limiting dilution.

All of the clones obtained by this method were found

to be permissive to BCV, but there was some variation in the way virus
infection was expressed cytopathically.
The HRT-18 cell line was established from an adenocarcinoma of the
lower gastrointestinal tract.
nuclei and scanty cytoplasm.

These cells are epithelial, with large
By ultrastructural examination, numerous

uniform, frequently parallel microvilli are evident.

The microvilli

cover the apical surface of the cells, closely resembling the brush
border of intestinal epithelium.

Cytogenetic analysis of HRT-18 at the

thirty-second passage showed a mode of 48 chromosomes, but additional
chromosomes appeared randomly, mostly in karyotype groups D and E.
Chromosome loss was not evident (122).
The purpose of this investigation was to analyze putative
differences between four HRT-18 cell clones, 3F3, D2, 3E3, and 4B3.
clones were characterized according to cell morphology, growth
32
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properties, and plating efficiencies.

Further, these cells were

infected with BCV-L9 to assess the susceptibility of each clone to
infection based on cytopathic expression of the virus.

III.B.
III.B.l.

MATERIALS AND METHODS
Cells and Media

HRT-18 clones 4B3, D2, 3E3, and 3F3 were isolated from HRT-18 cells
at approximately the 30th passage level by limiting dilution, and stocks
were prepared.
experiments.

All clones were at the 8th passage level for these
HRT-18 parent cells were used at passage 55 for these

investigations.

Cells were grown in Dulbecco's Modified Minimum

Essential Medium (DMEM) with 44 mM NaHCO^ buffer.

Penicillin (100

units/ml)-streptomycin (100 ug/ml) was added to the medium.

Medium was

supplemented with 5% fetal calf serum for routine cell maintenance, but
no serum was used during virus propagation.

III.B.2.

Screening for Contaminating Mycoplasma or Viruses

Culture supernatant was inoculated into Modified Hayflick broth (96)
then streaked onto Modified Hayflick Agar containing 1000 IU/ml of
Penicillin G to assay for contaminating Mycoplasma.

Cells were also

examined on the ultrastructural level for Mycoplasma or contaminating
viruses using transmission and scanning electron microscopy.

III.B.3.

Immunofluorescent Analysis of Plaques Formed by BCV-L9 in
HRT-18 Cells

Confluent monolayers of HRT-18 cells in 6-well polystyrene plates
were inoculated with 0.5 ml of 10-fold serially diluted BCV-L9.

After a

1 h adsorption period, excess inoculum was aspirated from the wells,
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cells were washed, and 3 ml of DMEM containing 0.6% agarose (Gibco,
electrophoresis grade) was added to the wells.
incubated at 37°C in 5% CC^.

The plates were

Cells were fixed at 48 h post infection

with 4% paraformaldehyde for 15 min, and the overlays were removed.
Cells were rinsed with PBS, pH 7.4, then post-fixed with methanol for 5
min., rinsed with PBS, and dried.

Serum 1745 (a bovine serum for tissue

culture) was diluted 1:20 in PBS, added to the wells, and incubated at
37°C for 30 min.
dried.

Cells were washed 3 times for 5 min. each with PBS and

Rabbit anti-bovine IgG (H and L chain) FITC-conjugated antiserum

(U.S. Biochemical Corp.) was diluted 1:16 in PBS, added to wells, and
incubated at 37°C for 30 min.

Three 5 rain. PBS washes were done as

before, and cells were dried.

A 0.002% Evan's blue solution was used to

counterstain the cells for 2 min., then the cells were briefly rinsed
with PBS and dried.

A drop of buffered glycerol mounting medium was

used to mount coverslips, and coverslips were sealed with nail polish.
Plaques were examined microscopically using a Zeiss epifluorescence
microscope equipped with a 40 X oil immersion lens.

III.B.4.

Virus

BCV strain L9 was adapted to cell cultures by Mebus et al (84) using
bovine fetal kidney cells.

The virus used in these investigations was

passaged 42 times in bovine fetal kidney cells, 16 times in bovine fetal
brain cells, 15 times in bovine fetal spleen cells, and 8 times in
HRT-18 cells.

III.B.5.

Infection of Cells

Monolayers of each HRT-18 clone in 25 cm2 tissue culture flasks were
infected with BCV-L9 at a multiplicity of infection (MOl) of
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approximately 3 x 10

PFU/cell.

Following an adsorption period of 1 h

at 37°C, excess inoculum was removed, and DMEM was added to the cells.
Infected flasks were incubated for three days, then cytopathic
expression was monitored by phase-contrast microscopy and photographed.

III.B.6.

Analyses of Cell Morphology

Confluent flasks of each clone were trypsinized and viable cell
counts were made using the trypan blue exclusion method and a
hemacytometer.

60 mm Petri plates were seeded with 1 x 10^ cells.

After 24, 48, and 72 h incubation, cells were fixed with Bouin's
solution and stained with Giemsa.

Confluent monolayers (4 days after

passage) of each clone were examined by phase-contrast microscopy and
photographed.

III.B.7.

Evaluation of Growth Properties

Following viable cell counts (described above) cells were seeded
into 25 cm

2

flasks at a density of 2 x 10

Flasks were incubated at 37°C.

5

cells/ml in 5 ml medium.

At 24 h intervals duplicate flasks of

each cell type were trypsinized and viable cell counts were made.

The

average cell count at each time period was calculated, and growth curves
were drawn by plotting viable cells versus time (h).

From the growth

curves the doubling time, generation time, population density, and
saturation density for each clone was extrapolated.

Doubling time was

the number of hours required for viable cell count to reach 2 x 10^
cells.

Generation time was obtained by averaging 3 doubling times taken

from the logarithmic phase of growth.

The saturation density (maximum

number of viable cells obtained) was the value where three successive
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cell counts showed no increase in number.

The population density was

2
the saturation density/cm .

III.B.8

Evaluation of Plating Efficiency

Triplicate 60 mm Petri plates were seeded with 100, 500, 1000, or
10,000 viable cells in 5 ml medium.

CO^.

Plates were incubated at 37°C in 5%

After a 6 day incubation period, cells were fixed with Bouin's

solution and stained with Giemsa.

Colonies consisting of 4 or more

cells were counted, and the plating efficiency was calculated as follows
(38):

No. colonies formed x 100
No. cells seeded

The plating efficiency reported was the average of the three plates
counted.

III.B.9.

Plating Efficiency in Soft Agar

The efficiency of colony formation in soft agar was assessed
according to a modification of the method used by MacPherson and
Montagnier (79).

Base layers of 7 ml medium containing 0.5% agarose in

60 mm Petri dishes were allowed to solidify.

A second layer seeded with

100, 500, 1000, or 10,000 cells in 1.5 ml medium plus 0.3% agarose was
added.

Plates were prepared in triplicate for each clone and incubated

at 37°C in 5% CO 2 .

Cell counts were done after 9- and 21-day

incubations, as follows:

Plates were sectioned into quarters.

All

cells within microscopic fields at a fold magnification of 200 X were
counted until a total of 25 cells per quarter had been counted.

The

number of colonies within this population which contained 4 or more
cells was determined.

The efficiency of colony formation was the

average of the triplicate counts.

III.B.10.

Statistical Methodology

The Statistical Analysis System (105) was used to analyze the data
with the general linear models (GLM) procedure and Tukey's Studentized
Range Test for analysis of individual mean differences.

All individual

mean separation tests were considered significant at a probability level
of 0.05.

III.C.

RESULTS

III.C.l.

Screening for Contaminants

No contaminating Mycoplasma or viruses were evident in culture or by
ultrastructural examination.

III.C.2.

Immunofluorescent Analysis of Plaques Formed by BCV-L9 in
HRT-18 Cells

Microscopic evaluation of the fluorescent antibody-stained plaques
revealed fluorescing cells within the center of the plaques, indicating
the presence of BCV-L9 antigen.

Among the fluorescing cells within the

plaque center were many cells which did not express viral antigens (Fig.

III.l).
III.C.3.

Analyses of the Morphology of HRT-18 Clones

HRT-18 clones, like the parent cells, were polygonal in shape.

The

nuclei were large and ovoid to pleomorphic and surrounded by a meager
cytoplasm.

Some differences in developmental morphology were seen in

Giemsa-stained cultures.

After 24 h growth, only a few single cells

were present in clone 3F3 cultures.

Well-defined, tightly-packed

colonies of different sizes had developed (Fig.

III.2.A).

Giemsa-

stained cultures of clone D2 consisted of a large number of single
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cells.

Colonies formed by this clone were poorly defined and loosely

associated (Fig. III.2.B).

Clone 3E3 produced small, discrete colonies

of similar size within 24 h (Fig. III.2.C).

Some large, densely-packed

colonies were formed by 4B3 cells, but most colonies consisted of only a
few cells (Fig. I1I.2.D).

Within 72 h, clones 3F3, 3E3, 4B3 had

coalesced into confluent monolayers but, growth was slower for clone D2.
Although difficult to demonstrate in a single micrograph, each clone
exhibited characteristic patterns within the monolayer that were evident
by phase-contrast microscopy.

The patterns included a distinct surface

topography and orientation of cells that was consistent and reproducible
with subpassage.

Vacuolation of cells occurred for each clone, but it

consistently appeared earliest in clone D2, and to lesser extents in the
other three clones (Fig. III.3.A-D).

III.C.4.

Assessment of Growth Properties of HRT-18 Clones

The growth curve of each cell type showed the classical lag,
logarithmic, stationary, and death phases of growth (Fig. III.4).

The

growth properties demonstrated by each clone are summarized in Table
III.l.

Each cell type exhibited a different doubling time.

The

shortest doubling time of 27 h was found for clone D2, while clone 4B3
required 52 h to double its cell population.

Clone 4B3 was the only

cell type to exhibit an initial decrease in viable cell count at the 24
h incubation period.

This drop in viable cells also occurred with the

HRT-18 parent cells, which had a 52 h doubling time.

The generation

times for clones 3F3, 4B3, D2, and parent cells were similar at 21, 21,
18, and 20 h, respectively, but it was 30 h for clone 3E3.

The kinetics
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of growth for clone 4B3 most closely resembled those of the HRT-18
parent cells.
Saturation densities for clones 3E3, 4B3, and D2 were approximately
8 million, while the saturation density was less than 7 million for
clone 3F3.
obtained.

Population densities of approximately 3 x 10

5

cells/cm

2

were

The maximum viable cell count for HRT-18 parent cells was 4

to 5 million cells higher than those of the clones, but these cells were
assayed in a separate experiment.

Therefore, the higher counts may be

attributable to slightly different culture conditions.

III.C.5.

Plating Efficiency

The plating efficiencies were determined by counting the number of
colonies of 4 or more cells per number of cells seeded.

The set seeded

with 100 cells was within the countable range, while the other three
sets were too numerous to count.

The plating efficiencies obtained for

each clone are reported in Table III.2.

Clones 3F3 and D2 plated with

efficiencies of 100% and 77%, respectively.

These values were

significantly higher (F = 30.76, p<0.0002) than those obtained for
clones 3E3 and 4B3 which had efficiencies of 33% and 50%, respectively.
Three basic colony types were apparent after Giemsa-staining:

small

colonies consisting of only a few cells; intermediate colonies of about
0.5 mm diameter; and large colonies of approximately 1 mm in diameter.
The colony types produced by the clones are given in Figures III.5.A-D.
All three types of colonies were produced by clone D2.
3E3 formed small and intermediate-sized colonies.
were produced by clone 4B3.

Clones 3F3 and

Mostly large colonies
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III.C.6.

Growth in Soft Agar as an Indicator of Transformation

Table III.2. presents the efficiencies of colony formation in soft
agar for each clone.

The efficiencies of clones 3E3 and 4B3 were

identical at 17%, and slightly lower at 15% for clone D2.
efficiency of 23% was produced by clone 3F3.

The highest

Statistical analysis did

not reveal significant differences between the clones.

III.C.7.

Cytopathic Expression of BCV-L9 in each Clone.

All four HRT-18 clones were susceptible to BCV infection, but the
cytopathic expression produced in each clone varied (Table III.3).
Clone 3F3 appeared to be the most susceptible to BCV infection because
it produced the most extensive CPE (Fig. III.6.A).

The monolayer was

heavily vacuolated, and areas of fused cells were observed.

The

cytopathic changes of infected clones D2 and 3E3 were less extensive
than 3F3.

Although milder, cytopathic expression also included

vacuolated monolayers and areas of cell fusion (Figs. III.6.B and C).
Based on cytopathic expression, clone 4B3 appeared the least affected by
infection (Fig. III.6.D).

Some vacuoles developed in the monolayer of

this infected clone, and some cells rounded up and detached.

Cell

fusion was not seen in clone 4B3.

Ill.D.

DISCUSSION

Turbid plaques are produced by BCV-L9 in HRT-18 cells.
Immunofluorescent analysis of these plaques revealed that many of the
cells within the plaques did not express viral antigen.

Presumably, the

non-fluorescing cells represent cells which are non-permissive to virus
infection or incapable of replicating internalized virus.

HRT-18 cell
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clones were established in an attempt to isolate both refractory and
susceptible cell types.
HRT-18 clones 3F3, D2, 3E3, and 4B3 were characterized to assess
putative differences between the cell lines.

The four clones exhibited

differences in morphology both in Giemsa-stained cultures and in 4--day
monolayers.

The basis for these differences is unknown.

The diversity

in colony size and number of single cells observed after 24 h incubation
probably reflects each clone's ability to readjust to culture following
trypsinization or differences in rate of growth.

Variation in the

cultural morphology may indicate differences in cell size, the
orientation of junctional complexes (desmosomes) between cells, and/or
varied degrees of contact inhibition.

These traits contribute to the

proximity between cells and the way the cells pile up in culture.

In

combination, these characteristics could contribute to the unique
cultural patterns displayed by each clone.

Vacuolization of the cells

was a morphological characteristic which probably reflects the aging
process.
Studies of the growth properties of the cells were conducted to
assess any variance between the clones in kinetics of growth.

Each

clone required a unique period of time to double in number, indicating
that the log or adjustment phases were dissimilar.
3E3 showed a similar generation time.

All clones except

Therefore, 3 of 4 clones

multiplied logarithmically at approximately equal rates, with clone 3E3
multiplying at a somewhat slower rate.

Similar saturation densities

were obtained by clones D2, 4B3, and 3E3, indicating that the growth
rates leveled off and allowed nearly the same cell numbers to be
achieved.

The maximum cell count was over 1 million cells fewer for
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clone 3F3.

The viable cell counts were reduced to a different level for

each clone at the final count of 260 h.

For example, the count did not

deviate from the saturation density for clone 3F3, but decreased by 4 x
10^ cells for clone 3E3.
The growth of the HRT-18 parent cells was assayed at a different
time than the clones, and the higher saturation density may have
resulted from slightly different culture conditions.

Clone 3F3 formed

colonies to the highest efficiency both under normal culture conditions
and in soft agar.

MacPherson and Montagnier (79) found that BHK- 21/13

cells, transformed by polyoma virus, formed colonies in soft agar medium
while uninfected cells did not.

This procedure demonstrates anchorage

independence and is an indicator of transformation.

All the clones

shared this transformed quality, but it was most apparent in clone 3F3.
It is likely that the extent of transformation is greatest in this
clone.

Perhaps transformed traits such as cell membrane changes or

increased metabolic activity contribute to the extreme susceptibility of
clone 3F3 to BCV infection.
According to a study of HRT-18 cells at passage 6-12 done by
Tompkins et al (122), the generation time for the cells was 31.1 h and
the plating efficiency was 91.3%.
those obtained for clone 3F3.

These data most closely resemble

This study demonstrated that HRT-18 at

passage 55 had a doubling time and generation time nearly identical to
clone 4B3.

Perhaps the growth properties of the HRT-18 cells shifted

from predominately 3F3-like characteristics at low passage to
predominately 4B3-like characteristics at high passage.
All four clones were susceptible to BCV infection, but the
cytopathic expression produced as a result of BCV infection differed
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between the clones.

Several plausible reasons may explain this result:

a) The clones may process the virus differently.

Cellular proteases may

be produced at different levels or not at all in some cells, allowing
the virus to replicate more efficiently in a particular clone.
Presumably, cell fusion is a consequence of proteolytic cleavage and
activation of the cell-fusing ability of this virus.

Frana and

coworkers (37) demonstrated varied ability to induce cell fusion when
four different murine cell lines were infected with MHV.
lines processed the 180 Kd glycoprotein differently,
membrane plays a major role in cell fusion.

These cell

b) The cell

Huang (57) showed that

glycolipids are involved in membrane fusion.

Glycolipids containing

galactose at terminal positions inhibited hemolysis and fusion of
erythrocytes by Sendai and influenza viruses.

The investigator assumed

that the lipids interfered with the fusion process by competing with
viral glycoproteins responsible for fusion.

In studies of liposome

fusion by Sendai virus, the presence of gangliosides in the liposomes
was essential for fusion (44,45).

Miyake and other investigators (88)

demonstrated the involvement of the cytoskeleton in cell fusion by
disrupting microfilaments with cytochalasin D and inhibiting fusion.
Therefore, it is quite possible that the appearance of cell fusion in
clones 3F3, D2, and 3E3 but not 4B3 may reflect differences in the
composition of the cell membranes,

c) The HRT-18 clones possibly have

different receptor proteins on their surfaces, or the virus receptor may
appear more frequently on certain clones.
different levels of infection.

This would contribute to

The lack of a virus receptor on the

target tissues of mice genetically resistant to MHV was demonstrated
(8).

d) Perhaps the replication and/or morphogenesis of the virus
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occurs with varied efficiency in the clones.

Lytic infections with MHV

showed coordinated synthesis of viral proteins throughout infection,
while in non-cytocidal infections, synthesis of the N protein appeared
earlier.

Pulse-chase experiments demonstrated different rates of

shut-down of host protein synthesis for MHV-infected cells (117).

Any

one of these phenomena or a combination of them may explain the
differences that the clones exhibit in expression of virus infection.
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Table III.l.

Growth Properties of HRT-18 Cells

Doubling

Generation

Saturation

Time (h)

Time (h)

Density (cells)

Density (cells/cm )

3F3

30

21

6.7 x 10

2.7 x 10"

3E3

36

30

8.1 x 10

3.2 x 10"

4B3

52

21

7.6 x 10

3.0 x 10"

D2

27

18

8.3 x 10

3.3 x 10'

HRT-18
parent

52

20

11.9 x 10

4.8 x 10'

Clone

Population
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Table III.2.

Efficiencies of Colony Formation for HRT-18 Cell Clones

Efficiency of Colony Formation
Clone

Plating Efficiency

in Soft Agar

3F3

100 %

23%

3E3

33%

17%

4B3

50%

17%

D2

77%

15%
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Table III.3.

Cytopathic Expression of BCV-L9 in HRT-18 Cell Clones

Clone

Extent of
Cytopathic
Expression

4B3

Minimal

Cytopathic Expression

Vacuoles
Cell rounding

D2

Moderate

Vacuoles
Cell fusion

3E3

Moderate

Vacuoles
Cell fusion

3F3

Extensive

Vacuoles
Cell fusion

\
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Figure III. 1.

Photomicrograph of a Plaque Produced by BCV-L9
in HRT-18 Cells and Examined by
Immunofluorescent Analysis.

Magnification - 400 X

/
Figure III. 2.

Photomicrograph of Giemsa-Stained, 24 h Cultures
of HRT-18 Clones.
C.

Clone 3E3

100 X

D.

A.

Clone 3F3

Clone 4B3

B.

Clone D2

Magnification -

Figure III. 3.

Phase-Contrast Photomicrograph of Confluent
Monolayers of HRT-18 Clones.
Clone D2

C.

Clone 3E3

Magnification - 200 X

D.

A.

Clone 3F3

Clone 4B3
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1 21

4B3
D2

10Viable Cells X 10

3E3

40

^

3F3

-♦

HRT-18
parent

80
Time (hours)

\

Figure III. 4.

Growth Curves of HRT-18 Clones and Parent Cells.

Photomicrograph of Colonies Produced by HRT-18
Clones.
B.

Giemsa-Stained Cultures.

Clone D2

C.

Clone 3E3

Magnification - 100 X

D.

A.

Clone 3F3

Clone 4B3.

Figure III. 6.

Phase-Contrast Photomicrograph of
BCV-L9-Infected HRT-18 Clones.
B.

Clone D2

C.

Clone 3E3

Arrows indicate fused cells.
Magnification - A,B - 200 X

A.
D.

Clone 3F3
Clone 4B3.

CHAPTER IV.

INFLUENCE OF HOST CELL, VIRUS STRAIN, AND TRYPSIN
MODIFICATION ON BCV CYTOPATHIC EXPRESSION AND PLAQUE
FORMATION.

IV.A.

INTRODUCTION

An infectious form of Sendai virus was produced in chicken embryos.
The virus was hemolytic and activated cell fusion.

Propagation of

chicken embryo-borne Sendai virus in L cells resulted in a single round
of replication, and the L cell-borne Sendai virus was noninfectious,
nonhemolytic, and did not induce fusion.

Treatment of the L cell-borne

virus with trypsin activated the three biological activities.
Activation of the virus was a result of cleavage of the inactive
precursor protein Fo to the subunits Fl and F2 which are disulfide
linked to form the active F protein (51-54,93,99,106).

Proteolytic

activation of viral infectivity was also reported for Newcastle disease
virus and orthomyxoviruses (24,39,99).
Coronaviruses appear to have a dependence on the host cell for
replication in culture.

The spectrum of cytopathic expression ranges

from mild to highly cytocidal according to the virus strain and the host
cell.

Cytocidal infections may cause cell fusion and polykaryon

development or cell lysis.

In contrast, persistent coronavirus

infections were reported in some cell lines (23,48,75).
coronavirus do not replicate in culture.

Many strains of

Frana and coworkers (37)

reported host-dependent processing of the structural proteins of
MHV-A59.

They found that activation of the viral fusion factor was due

in part to cleavage of the 180 Kd peplomer to 90 Kd subunits.

Trypsin

enhanced the cell-fusing activity of this virus (37,119,135).

A

trypsin-dependent increase in cell-fusing activity and plaque
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development of bovine coronavirus was demonstrated using bovine fetal
brain and bovine fetal thyroid cells (114).
The purpose of this study was to determine the effect of the host
cell, virus strain, and trypsin modification on the cytopathic
expression and plaque development of bovine coronaviruses.

For this

investigation cells which varied in susceptibility to infection were
used, and several wild-type virus isolates, as well as strain L9 were
assayed.

IV.B

MATERIALS AND METHODS

IV.B.l.

Cells

HRT-18 parent cells and HRT-18 cell clones 3F3, D2, 3E3, and 4B3
were maintained as described in Chapter III.
from bovine fetal spleen cells.

D2BFS cells were derived

They are a population of cells which

survived precrisis and continue to multiply well past the thirtieth
passage.

D2BFS cells were maintained in Eagle's Minimum Essential

Medium (MEM) containing 25 mM Hepes and penicillin (100
units/ral)-streptomycin (100 ug/ml).
calf serum.

IV.B.2.

MEM was supplemented with 10% fetal

No serum was used in the presence of virus.

Virus

BCV-L9 and 5 wild-type strains (isolated from Colorado and Utah)
were used.

Wild-type isolates were designated Meeker, Miller, Fisher,

Calf 50, and LY-138.

These isolates were obtained from diarrhea fluids

of sick calves and were passaged 2-3 times in HRT-18 cells.
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IV.B.3.

Propagation of Virus in Different Cells

Monolayers of HItT-18, clones, and D2BFS cells in 25 cm
infected in duplicate with BCV.
-3
10
PFU/cell.

flasks were

BCV-L9 was inoculated at an MOI of 3 x

Stock wild-type strains were inoculated at approximate

MOIs of 1 and 0.1 PFU/cell.
III.

2

Cells were infected as described in Chapter

Following a 1 h adsorption period, excess inoculum was removed,

and 5 ml of medium was added.

One flask from each set received

trypsin-free medium, the other set received medium + the maximum
concentration of trypsin which did not produce damage to the cell
monolayers.

5 ug/ml trypsin was used with HRT-18 cells; 7.5 ug/ml

trypsin (Difco 1:250) was used with D2BFS.

All flasks were incubated at

37°C and monitored daily for CPE.

IV.B.4.

Plaque Formation

Confluent monolayers of HRT-18 cell clones 3F3, D2, 3E3, and 4B3 in
6-well polystyrene plates were infected with 10-fold serially diluted
virus (0.5 ml/well in paired wells).

The overlay medium consisted of

DMEM + 0.6% agarose (Gibco, electrophoresis grade).

Trypsin (Difco,

1:250, 2.0 ug/ml) was added to the overlay of half the wells.

After a

3-4 day incubation period, cells were stained for 2 h with neutral red,
fixed with formalin saline for 10 min., and the overlays were removed.

IV.C.
IV.C.l.

RESULTS
Cytopathic Expression of BCV in Different Cells

The cytopathic expression of five wild-type BCV strains and strain
L9 were analyzed in the presence and absence of trypsin using HRT-18
parent cells, four HRT-18 cell clones, and D2BFS cells.
this investigation are given in Table IV.1.

The results of

HRT-18 cells were
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permissive to all strains of virus.

These cells were initially used for

isolation of wild-type strains from diarrhea fluids and adaptation of
the viruses to culture.

Each strain of virus induced cell fusion in

HRT-18 cells, and trypsin enhanced the cytopathic expression.

Extensive

fusion occurred in HRT-18 cells infected with strains L9 and Meeker in
the presence of trypsin, while moderate fusion was a result of infection
with strains Miller, Fisher, Calf 50, and LY-138.

The cytopathic

expression resulting from infection of HRT-18 cells with BCV-L9 with and
without trypsin is demonstrated in Figure IV.1.

D2BFS cells were

non-permissive to infection by all the field isolates even in the
presence of trypsin.

Strain L9 replicated in D2BFS cells, but cell

fusion only occurred in the presence of trypsin (Fig. IV.2).

Strain L9

replicated with varied intensity in the four HRT-18 cell clones.
Trypsin increased the cytopathic expression in clones 3F3, D2, and 3E3,
but not in clone 4B3.

Cell fusion was observed in all clones except

clone 4B3.

IV.C.2

Plaque Development

The production of plaques by BCV-L9 was monitored in HRT-18 clones
3F3, 3E3, D2, and 4B3 both with and without trypsin to assess any
host-dependent differences in plaque formation (Fig. IV.3).

The virus

produced sharp, distinct plaques of 1-2 mm diameter in clone 3F3 within
4 days post infection, and the plaques developed within 2-3 days in the
presence of trypsin.

The plaque diameter more than tripled, the plaques

were less turbid, and they were more sharply defined when trypsin was
included in the overlay.
were apparent.

At least 4 different plaque phenotypes of L9

Small, turbid plaques of approximately 1-2 mm diameter
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developed in clone 4B3.

The plaques were more distinct in the presence

of trypsin but the plaques remained turbid, and the diameter was
unchanged.

Distinct plaques of about 0.5-2 mm diameter were formed by

L9 in clone D2.

Trypsin did not increase the size of these plaques, but

the plaques were slightly less turbid and easier to see.

Plaques were

not evident in the 3E3 cell monolayer in the absence of trypsin.
Plaques remained indistinct, but they were apparent in wells containing
trypsin.
Based on cytopathic changes, HRT-18 clones 3F3 and 4B3 represent
highly susceptible and minimally susceptible cells to BCV infection,
respectively.

Consequently, the two clones were used to assess plaque

formation by four wild-type strains of BCV.

Plaques were not produced

by any of the isolates in clone 4B3 either in the presence or absence of
trypsin.

In clone 3F3, plaques developed readily, and they were

enhanced by trypsin (Fig. IV.4).
were produced by strain Miller.

Plaques ranging in size from 2-4 mm
The number of detectable plaques

increased with trypsin, but the plaques remained relatively turbid and
of similar size to those produced without trypsin.

The plaques formed

by strain Meeker were 1 mm or 2 mm in diameter with fairly clear
centers.

These plaques were greatly enhanced by trypsin.

Plaque

diameters at least doubled, and the centers were very clear.

Strain

Calf 50 produced turbid plaques of 1-2 mm diameter in the absepce of
trypsin.

Plaques that developed with trypsin in the overlay were less

turbid, but the size of the plaques did not increase significantly.
LY-138 formed mostly medium-sized, turbid plaques of about 2 mm diameter
in the absence of trypsin.

Some of the plaques were enhanced by

trypsin, but other plaques within the monolayer exhibited no enhancement.
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IV.D.

DISCUSSION

Host-dependent differences in the cytopathic expression of bovine
coronaviruses were demonstrated in this study.

HRT-18 parent cells

allowed the replication of all strains of BCV.

The four HRT-18 clones

were permissive to infection with strain L9, and the cytopathic changes
were different in these cells.

In contrast, D2BFS cells only allowed

the replication of the cell-adapted virus strain, L9, while these cells
were non-permissive to infection by the wild-type strains.
Cell fusion was induced by all strains of virus in HRT-18 parent
cells, and strain L9 induced fusion in clones 3F3, 3E3, and D2.
enhanced the CPE and cell fusion in these cells.

Trypsin

Fusion was not evident

in L9-infected clone 4B3 either with or without trypsin.

These cells

may be incapable of fusion due to the composition of the cell membrane
(44,45,57,88), or they may process the virus differently.

Cell fusion

occurred in L9-infected D2BFS cells only in the presence of trypsin.
This finding indicates that these cells may lack a specific protease
necessary for activating the cell-fusing activity of the virus.

This

situation is analogous to that found for Sendai virus propagated in L
cells, which was reported by Homma and others (51,52,54).
Plaque formation was dependent upon the host cell line, the strain
of virus, and the presence of trypsin in the overlay.

Strain L9

produced plaques in the four HRT-18 cell clones, but the ease of plaque
production and the morphology of the plaques varied between the cells.
Differences in the rate of replication of the virus in the clones could
produce this result.

Within a given incubation period, larger plaques

would form in cells which allow rapid replication of the virus, while
smaller plaques would develop in cells in which the virus replicates
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slowly.

Trypsin dramatically enhanced the morphology of plaques

produced in clone 3F3, but the morphology of the plaques formed in
clones D2, 3E3, and 4B3 were less affected by trypsin.

Enhanced plaque

production of BCV-L9 by trypsin was also demonstrated in bovine fetal
brain and thyroid cells (114).
Clone 4B3 was nonpemissive to plaque production by the wild-type
BCV strains, but plaques developed readily in clone 3F3, again
demonstrating the host-dependence of BCV replication.

Each wild-type

strain produced a number of distinct plaque phenotypes that were
enhanced by trypsin.

Since these virus stocks were not plaque purified,

they probably consist of a variety of genotypically distinct viruses.
BCV-L9 is a highly cell-adapted strain of virus which replicates
easily in culture.

In contrast, the wild-type strains were isolated

from diarrhea fluids and were passaged only 2-3 times in cultures of
HRT-18 cells.
culture.

The wild-type strains differ in cytopathogenicity in

Williams (132) reported differences in the polypeptide

profiles of these viruses.

Structural differences may affect the

viruses' ability to adsorb to or replicate in a cell type, or affect the
ease and extent of processing of viral proteins by the host cell or by
trypsin.

These factors probably contribute to the differences in

cytopathic expression and plaque development observed in this study.

Table IV.1.

Cytopathic Expression of BCV Strains in Different Cell
Types.

Cells

Trypsin

L9

Miller

D2BFS

A

+

-

-

-

-

-

-

-

-

-

-

HRT-18
parent

Clone
4B3

Clone
D2

Clone
3E3

Clone
3F3

Meeker

Fisher

Calf 50

LY-138

P

++(ef)

A

+ (lf)

+ (lf)

+ (lf)

+ (lf)

+ (lf)

P

++(ef)

++(mf)

++(ef)

++(mf)

++(mf)

++(mf)

ND

ND

ND

ND

ND

ND

ND

ND

ND

ND

ND

ND

ND

ND

ND

ND

ND

ND

ND

ND

A

+

P

+

A

+ (lf)

P

++(mf)

A

+ (lf)

P

++(mf)

A

+ (mf)

P

++(ef)

(If) - light fusion
(mf) - moderate fusion
(ef) - extensive fusion
A - trypsin absent
P - trypsin present
ND - not done

+
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Figure IV. 1.

Phase-Contrast Photomicrograph of
BCV-L9-Infected HRT-18 Cells.
B.

(+) trypsin

Magnification - 100 X

A.

(-) trypsin

Photomicrograph of BCV-L9-Infected D2BFS Cells
Giemsa-Stained Cultures.
A.

(-) trypsin

Magnification

B.

- 400 X

(+) trypsin
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Figure IV. 3.

Plaque Development of BCV-L9 in HRT-18 Clones
3F3, 4B3, D2, and 3E3.
p - trypsin present.

a - trypsin absent,
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M e ek er

LY138

Figure IV. 4.

Plaque Development of Wild-Type BCV Strains in
Clone 3F3.
present.

a - trypsin absent, p - trypsin

CHAPTER V.

THE INFLUENCE OF THE HOST CELL AND TRYPSIN TREATMENT ON BCV
INFECTIVITY.

V. A.

INTRODUCTION

Proteolytic cleavage of surface proteins is a prerequisite for
infectivity in a number of virus systems.

Specifically, orthomyxovirus

requires cleavage of the 75-80 Kd HA protein into the 36 Kd HA1 and and
the 27 Kd HA2 species for the virus to be infectious.

Activation of the

cell-fusing potential and infectivity of paramyxovirus is a result of
cleavage of the Fo precursor protein into FI and F2 (52 and 13 Kd,
respectively) which are disulfide-linked subunits of the active F
protein.

Activation of the infectious potential of these two viruses is

accomplished either by cellular proteases or by trypsin
(25,39,51-54,92,99,106).

The infectivity of rotaviruses can be

increased if the outer capsid polypeptide VP3 is cleaved into VP5 and
VP8 (60 Kd and 28 Kd, respectively).

Cleavage by trypsin, elastase, or

pancreatin causes an increase in infectivity of rotaviruses (35,74).
Proteolytic cleavage of the 180 Kd envelope protein of MHV into its
90 Kd subunits activates the cell-fusing activity of this virus, but
this cleavage pattern has not been correlated to an increase in the
infectivity of the virus.

Cell-dependent differences in processing of

MHV proteins have been demonstrated (37,119).

Trypsin enhances the

plaque development and the cell-fusing capacity of murine, bovine, and
avian coronaviruses (97,114,135).

The polypeptide profile of BCV is

altered by trypsin treatment (133).

Toth (124) found that the rate of

replication and the infectivity of BCV was enhanced when the virus was
propagated in bovine embryonic lung cells in the presence of trypsin.
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In the previous chapter the effect of the host cell, virus strain,
and trypsin modulation on the cytopathic expression and plaque
development of bovine coronaviruses was examined.
parameters affected the growth potential of BCV.

All three of these
The intent of this

experimentation was to determine the influence of the host cell and
trypsin treatment on the infectivity of the virus.

V.B.

MATERIALS AND METHODS

V.B.l.

Cells and Virus

HRT-18 parent cells, HRT-18 clones 3F3, D2, 3E3, and 4B3, and D2BFS
cells were maintained as described in previous chapters.

BCV strains L9

and LY-138 were used in these assays.

V.B.2.

Propagation of Virus in the Presence and Absence of Trypsin

Cells were cultured in 25 cm

2

tissue culture flasks until confluent.

Cells were washed with Dulbecco's PBS and infected in duplicate with BCV
— 9

strain L9 or LY-138 diluted 10- 10
was 3 x 10“3 - 3 x 10~7 PFU/cell for

—

Using

L9 the approximate MOI

HRT-18 and

3 x 10_2 -3 x 10~6
_2

PFU/cell for D2BFS.
PFU/cell for LY-138
h at 37°C.

The approximate MOI was 1.4 x 10

—A

to1.4 x 10

in HRT-18 cells. Virus was allowed to adsorb for 1

For each cell type, paired flasks received either medium or

the same medium containing trypsin.

HRT-18 parent cells and clones

received 5 ug/ml trypsin; D2BFS cells received 7.5 ug/ml trypsin.
flasks were incubated at 37°C for 48 h with CPE monitored daily.

All
Flasks

were frozen at -70°C, thawed, sonicated for 15 sec, and aliquots were
frozen.

Samples were titrated for virus yields by hemagglutination

assay and plaque assay.
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V.B.3.

Hemagglutination Assays

1% mouse erythrocytes were used for detection of BCV hemagglutinin.
Two-fold serial dilutions of 25 ul virus samples were made in 96-well
microtiter plates using PBS as diluent.

Mouse red blood cells were

added, and plates were agitated to assure mixing in wells.

Plates were

incubated at room temperature for 2 h or overnight at 4°C, then examined
for agglutination of red blood cells.

V.B.4.

Plaque Assays

Plaque assays were used to enumerate infectious virus.

The assays

were performed as described in the preceding chapter usinga 0.5 ml
inoculum.

V.B.5.

Assessment of Infectious Units in the Virus Population

PFU:HA ratios were calculated from the titers obtained from plaque
assays and hemagglutination

assays.

A 0.5 ml inoculum was used in

plaque assays, and a 25 ul sample was tested by hemagglutination assay.
These values represent the amount of infectious virus per
hemagglutinating unit.

Graphs were plotted as

PFU:HA versus

inoculum virus dilution.

V.B.6.

Propagation of BCV-L9 Using Different Trypsin-Treatment Schemes

Duplicate 25 cm

2

flasks of confluent D2BFS cells were treated as

follows:
Set 1)

Cells were washed three times with Dulbecco's PBS, then treated

with 2 ml of MEM containing 1 ug/ml trypsin (Sigma, TPCK treated).
Cells were incubated for 10 min at 37°C.

Cells were washed to remove

trypsin, then infected with L9 propagated in D2BFS cells without trypsin
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(MOI = 6 x 10 ^ PFU/cell).

After adsorption for 1 h at 37°C, excess

inoculum was removed, and cells were washed.

MEM without trypsin was

added to the flasks.
Set 2 - Cells were washed and infected with virus as described above.
After adsorption, MEM containing 1 ug/ml trypsin was added to
Set 3 - Virus was treated with 1 ug/ml trypsin

for 30 min.

flasks.
at37°C.

Trypsin activity was stopped by adding 1 ug/ml soybean trypsin inhibitor
(Sigma) and incubating for 30 min. at 4°C.

Virus was diluted to an MOI

-4
of 6 x 10
PFU/cell and used to infect cells.

After adsorption, medium

lacking trypsin was added to the flasks.
Set 4 - The virus was treated with trypsin as described above, then
immediately diluted and used as inoculum.

MEM containing 1 ug/ml

trypsin was added after adsorption.
Set 5 - Cells were washed and infected with virus as described above.
After adsorption MEM without trypsin was added.
All flasks were incubated for 24 h, then frozen at -70°C.
were thawed, sonicated, and aliquots were frozen.

Cells

Yields were titrated

from duplicate samples obtained from replicate flasks by plaque assay in
HRT-18 cells.

V.B.7.

The four values were averaged to obtain the PFU titer.

Statistical Methodology

The Statistical Analysis System (SAS) (105) was used to analyze the
data with the general linear model (GLM) procedure and Tukey's
Studentized Range Test for analysis of individual mean differences.
individual mean separation tests were considered significant at a
probability level of 0.05.

All
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V.C.

RESULTS

V.C.l.

Effect of Trypsin on BCV Infectivity

Infectivity ratios are displayed graphically as log^Q PFU:HA versus
inoculum virus dilution.

An increase in PFU:HA occurred at dilutions

-4
-5
10
and 10
when BCV-L9 was propagated m

D2BFS cells.

At these

dilutions there was no detectable infectious virus in the absence of
trypsin, but a PFU:HA of greater than 5 log units occurred with trypsin.
Enhanced infectivity was not apparent at lower dilutions of virus (Fig.

V.l).
The infectivity ratios produced in HRT-18 parent cells were nearly
-2
-5
identical with and without trypsin at BCV-L9 dilutions of 10
- 10
At the 10 ^ dilution of inoculum, an increase in PFU:HA of 5 log units
was obtained (Fig. V.2).
The infectivity of BCV-L9 propagated in the HRT-18 clones was less
dramatically affected by trypsin, but definite trends in virus yields
were observed.

At the 10 ^ dilution of L9 propagated in clone 3F3, an

increase in PFU:HA of about 1 log unit occurred in the presence of
trypsin.

A consistent increase in the infectivity ratio did not occur

at lower dilutions (Fig. V.3).

Clone D2 produced a PFU:HA that was

■

increased by 1/3 log with trypsin at the 10 ^ dilution, and this slight
increase persisted at 10 ^ dilution (Fig. V.4).

The infectivity ratios

-2
-3
at the 10
and 10
dilutions were 1/2 to 1 log lower with trypsin in
clone 3E3.
at 10

-4

However, continuing the trend shown by all other cell types,

and 10

-5

dilutions of inoculum, the trypsin-treated sets

produced slightly elevated PFU:HA.

No detectable virus was produced

when the dilution was 10 ^ (Fig. V.5). A reverse trend occurred when L9
was propagated in clone 4B3 with or without trypsin.

At the highest
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dilution, an infectious yield of nearly 1 log unit higher occurred in
the absence of trypsin (Fig. V.6).
The wild-type strain LY-138 propagated in HRT-18 parent cells showed
no enhanced infectivity at dilutions 10

-2

—5
- 10 . A 1/2 log increase

was evident in the presence of trypsin at the 10 ^ dilution (Fig. V.7).
Figure V.8. shows the PFU:HA ratios with trypsin:without trypsin
obtained in each cell type at the highest dilution producing detectable
virus - the limiting virus dilution.

The ratios were 5:1, 2:1, and 3:1

for clones 3F3, D2, and 3E3 respectively, and less than 1 for 4B3.
Infinitely enhanced yields were produced by D2BFS and HRT-18 parent
cells in the presence of trypsin.
The PFU:HA ratios with:without trypsin were calculated for each cell
type at all dilutions of inoculum and are displayed graphically in
Figure V.9.

The purpose of this graph is to simplify the comparison of

the effects of trypsin on viral infectivity between the different cell
types.

Infinitely enhanced infectivity was apparent in D2BFS cells at

-4
.
the 10
inoculum dilution.
-4
3 x 10
PFU/cell.

. . .
This dilution represents an initial MOI of

HRT-18 cells produced infinitely enhanced viral

infectivity in the presence of trypsin at the 10 ^ dilution (initial MOI
of 3 x 10 ^ PFU/cell).

Therefore, enhanced viral infectivity occurred

at a 1000-fold higher MOI in D2BFS cells.

When L9 was propagated in

HRT-18 clones D2 and 3E3, trypsin enhancement of viral infectivity was
-4
evident at the 10
dilution.

A detectable increase in infectious virus

yields was evident in clone 3F3 cells at 10 ^ dilution, but at the same
dilution infectious yields were decreased by trypsin whei. L9 was assayed
from clone 4B3.
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V.C.2.

Effect of Different Trypsin-Treatment Schemes on Virus Yields

The yields of infectious virus produced in D2BFS cells under
different trypsin-treatment conditions was titrated in quadruplicate by
plaque assay in HRT-18 cells.
Figure V.10.

These data are displayed as i°gjQ PFU in

The PFU counts were essentially the same for pretreated

cells (set 1) and the control system (set 5).

Nearly identical

infectious yields were obtained when trypsin was added to infected cells
post infection (set 2) and when the inoculum was pretreated, then
trypsin was added post infection (set 4).

These values were

significantly higher than those obtained from sets 1 and 5 (F = 134.56,
p<0.0001).

The lowest yield was obtained from set 3 (inoculum

pretreated with trypsin, then soybean trypsin inhibitor).

This set was

significantly lower than all other treatments.

V.D.

DISCUSSION
The effect of trypsin on BCV infectivity was quantitated by

determining PFU:HA.

This ratio represents the amount of infectious

virus per heraagglutinating unit obtained from a given sample.

This

method of quantitation was chosen over a simple PFU titration because it
depicts the effect of trypsin on the entire virus population.

These

data represent consistent trends and are reported as such.
Trypsin enhanced the infectivity of BCV-L9 propagated in HRT-18
parent and D2BFS cells to infinite proportions.

The increase in

infectivity was apparent at a 100-fold lower inoculum dilution
(1000-fold higher MOI) in D2BFS cells.

L9 propagated in the HRT-18

clones exhibited differences in the amount of trypsin enhancement and
the dilution at which the increased yields appeared.

A plausible
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explanation for these phenomena is that bovine coronaviruses require
proteolytic processing to activate their infectious potential.

In a

given cell type, the pool of progeny virus consists of two forms of
virus - infectious and noninfectious, reflecting the cell's ability to
process the virus to the infectious form by endogenous protease.

With

dilution the supply of infectious virus in the inoculum is minimized,
emphasizing the cell's ability to produce infectious virus.

Trypsin

converts noninfectious progeny virus to the infectious form, thereby
enhancing the infectivity of the virus yield.

Therefore, cells with a

high capacity for production of infectious progeny require a higher
dilution of inoculum before trypsin enhancement is apparent.

If the

ratio of infectious virus exceeds noninfectious virus, then trypsin
enhancement is not detectable.

Such an event would explain the marginal

trypsin effect in the HRT-18 clones.

It is likely that HRT-18 parent

cells are innately capable of producing high yields of infectious BCV,
unlike D2BFS cells, which require the addition of trypsin for activation
of the virus.

It is evident from these investigations that trypsin-like

proteases are required to activate the infectivity of BCV in some
cultured cells.
Interestingly, the effect of trypsin on the infectivity of L9
correlates well with the results of the cytological studies described in
the preceding chapters.

The CPE produced in D2BFS and HRT-18 cells was

enhanced by trypsin, and the four HRT-18 clones varied in response to
trypsin treatment.

Clone 4B3, which was only minimally affected by L9

with or without trypsin, was the only cell line to produce lower
infectious yields in the presence of trypsin.
this finding is not fully understood.

The molecular basis for
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LY-138 was slightly enhanced in infectivity when propagated in
HRT-18 cells, as compared to the dramatic increase shown with L9.
Williams (132) found differences in the protein profiles of
trypsin-treated L9 and LY-138, although their untreated profiles were
nearly identical.

This indicated that the two strains are cleaved

differently, a trait which may account for differences in the infectious
potential of the viruses.
Different trypsin-treatment conditions of L9-infected D2BFS cells
were employed to discern the target of trypsin action.

It was found

that pretreatment of cells with trypsin had no effect on the production
of infectious virus.

It was concluded that any putative effect that

trypsin exerted on the host cell did not affect virus production.

On

the other hand, the presence of the enzyme in culture medium enhanced
the virus titer.

In this case, trypsin had access to the progeny virus

and probably activated noninfectious particles to the infectious form as
previously discussed.

Trypsin alters the polypeptide profile of BCV

(133), so it was considered likely that the effect would be exerted
directly on the virus.

However, pretreated inoculum produced the lowest

yields of all 5 sets.

Soybean trypsin inhibitor was not removed from

the system in this set.

Potential deleterious effects of the inhibitor

on the host cells or virus were not examined, but may have contributed
to the low yield.
From these studies it can be concluded that the infectivity of BCV
is dependent upon the host cell and trypsin modification.

Trypsin is a

constituent enzyme of the intestinal tract, the site of BCV replication
in the natural host.

Therefore, it may play a role in activation of

.virulent virus in natural infections.

Factors causing variance in BCV
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replication between cell types are unknown and must be assessed to fully
understand the mechanism of BCV infectivity in culture. Frana and
coworkers (37) found the murine coronavirus MHV-A59 to be dependent on
the host cell or trypsin treatment for activation of the cell-fusing
activity of the virus.

Proteolytic activation of infectivity has been

well documented in paramyxoviruses, orthomyxoviruses, and rotaviruses as
well (25,35,39,51-54,74,92,99,106).
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CHAPTER VI.

EFFECT OF THE HOST CELL AND TRYPSIN TREATMENT ON THE
POLYPEPTIDE PROFILE OF BCV-L9

IV.A.

INTRODUCTION

Proteolytic cleavage of inactive precursor polypeptides of assembled
virions into an active form is necessary for inducing the infectivity of
a number of viruses.

Notably, orthomyxoviruses and paramyxoviruses

require cleavage of envelope proteins for the viruses to become
infectious (24,25,39,51,52,54,92,93).

Such findings are emerging for

coronaviruses as well. Processing of the viral proteins is accomplished
either by cellular proteases or by exogenous proteases, such as trypsin.
Frana et al (37) found that processing of the 180 Kd glycoprotein of
MHV-A59 was host cell-dependent and affected the functional capacity of
the virus.

Those cells which fully cleaved the 180 Kd protein to its 90

Kd subunits activated rapid cell fusion.

Cells which cleaved the

protein incompletely required trypsin to activate rapid cell fusion.
Trypsin enhances the replication and cytopathic expression of bovine
coronaviruses.

In Chapter IV it was shown that fusion of BCV-L9-

infected D2BFS cells required trypsin, but the protein responsible for
cell fusion has not been determined.
Williams and Storz (133) detected two phenotypes of virus when
BCV-L9 was purified from HRT-18 cells by isopycnic centrifugation in
sucrose or CsCl gradients.

The dense and light forms of the virus had

3
densities of 1.255 and 1.223 g/cm , respectively.

The two virus forms

had distinct polypeptide profiles, and the light form was converted to
the dense form by in vitro trypsin treatment.
There were three objectives to this investigation.

The first

objective was to assess putative cell-dependent differences in the

86

87
protein composition of BCV-L9.

The virus was raised in HRT-18 parent

cells, HRT-18 clones 3F3, D2, 3E3, and 4B3, and in D2BFS cells, since
these cells display different cytopathic effects when infected with the
virus.

The second objective was to compare the protein profiles of in

vitro trypsin-treated or untreated L9 propagated in HRT-18 cells.

The

profiles were examined under reducing and non-reducing conditions to
assess the effect of the enzyme on the viral polypeptides. Assessment of
the structural proteins of BCV-L9 propagated in D2BFS cells in the
presence or absence of trypsin by Western blotting was the third
objective.

Cell fusion occurs with infected D2BFS cells only in the

presence of trypsin.

This technique was employed to identify the viral

protein(s) responsible for cell fusion.

VI.B.
VI.B.l.

MATERIALS AND METHODS
Cells and Virus

HRT-18 parent cells and four HRT-18 clones, 3F3, D2, 3E3, and 4B3
were grown in 850 cm

2

.

2

Corning roller bottles or in 150 cm

flasks.

When

seeded in roller bottles, DMEM containing 25 mM Hepes and 12 mM NaHCO^
was used to stabilize pH.

After 1 day incubation at 37°C, this medium

was replaced with standard DMEM (described in Chapter III).
were grown in MEM in 750 cm

2

glass roller bottles.

D2BFS cells

BCV-L9 was the virus

strain used in these studies.

VI.B.2.

Virus Propagation and Purification

Cells were infected with BCV-L9 at an MOI of 0.01-0.1 PFU/cell.
Following adsorption for 1 h at 37°C, excess inoculum was removed and
cells were washed three times with Dulbecco's PBS.
and cells were incubated at 37°C.

Medium was added,

MEM containing 5 ug/ml trypsin was
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added to bottles of infected D2BFS cells.

When CPE affected

approximately 80% of the monolayer, cells were frozen at -70°C.

Bottles

were thawed; the infected material was pooled into 250 ml centrifuge
bottles, sonicated, and refrozen.
Virus was purified from thawed cell lysate according to a
modification of the procedure described by Wege et al (128).
were done at 4°C.

All steps

NaCl was added to the collected fluid to a final

concentration of 0.5 M.
at 10,000 x g for 20 min.

Culture fluid was clarified by centrifugation
30% polyethylene glycol - 8000 was added to

the clarified supernatant to a final concentration of 10%, and mixed on
ice for 10 min.

The resulting precipitate was sedimented by

centrifugation at 10,000 x g for 30 min.

The precipitate was collected

in TNE buffer (0.01 M Tris-HCl, 0.01 M NaCl, 0.001 M EDTA) pH 7.4,
resuspended by sonication, and dispersed by Dounce homogenization.

The

slurry was centrifuged at 1000 x g for 10 min. to remove aggregates.
The suspension was centrifuged through a continuous 5-20% sucrose-TNE
gradient onto a 4 ml 60% cushion at 70,000 x g for 2 h.

The band at the

20-60 % interface was collected, diluted to less than 20% with TNE
buffer, and layered onto a continuous 20-60% sucrose-TNE gradient.
Tubes were centrifuged at 55,000 x g for 16-18 h.

Gradient fractions

were collected by puncturing the bottom of the centrifuge tubes.
Virus-containing bands were identified by hemagglutinating activity.
Fractions containing the highest HA titers were pooled and concentrated
by pelleting through a 5 ml 20% sucrose cushion for 2 h at 90,000 x g.
Virus was resuspended in TNE buffer.

The virus suspension was layered

onto a preformed CsCl-TNE gradient (1.0606 - 1.2886 g/cm ) and

89
centrifuged at 55,000 x g for 20 h to further purify the virus.

Bands

were collected as described above, concentrated, and resuspended in TNE.

VI.B.3.

Partial Purification or Concentration of Virus.

Partially purified or concentrated virus was of adequate purity for
immunoblot analyses.

Virus was propagated in HRT-18 clones grown in

roller bottles or 150 cm

2

flasks.

To partially purify the virus,

centrifuge bottles of pooled cell lysate were thawed, then clarified at
10,000 x g for 20 min. at 4°C.

Supernatant fluid was loaded onto

continuous 5-20% sucrose-TNE gradients and centrifuged at 70,000 x g for
2 h.

The resulting pellet was resuspended in TNE buffer, loaded onto

continuous 20-60% sucrose-TNE gradients, and centrifuged at 55,000 x g
for 16-20 h.

Bands were collected, concentrated, and resuspended as

described.
To minimize loss of virus, L9 was directly concentrated from D2BFS
cells.

D2BFS cells in 150 cm

2

flasks were infected with BCV-L9 at an

MOI of approximately 0.1 PFU/cell.
well to remove unadsorbed virus.

After adsorption, cells were washed
MEM was added to one set of flasks,

and MEM with 5 ug/ml trypsin (Difco 1:250) was added to the other set.
Flasks were incubated at 37°C for 3 days, then frozen, thawed, and the
cell lysate was pooled.

Fluid was clarified at 10,000 x g for 20 min.

to remove cell material.

The supernatant was centrifuged through a 5 ml

20% sucrose-TNE cushion for 2 h at 90,000 x g.

The pellet was

resuspended in TNE, concentrated, and resuspended as described.

VI.B.4.

Preparation of Uninfected Cell Antigen for Western Blots
2

Washed cells in 150 cm

flasks were frozen at -70°C, then thawed,

and cell material was collected in centrifuge tubes.

Cell material was
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sonicated for 1 min., then the suspension was centrifuged at 1000 x g
for 15 min. to settle nuclei.

The supernatant was centrifuged at 90,000

x g for 2 h, and the pellet was resuspended in TNE buffer.

VI.B .5.

In Vitro Trypsin Treatment

Aliquots of partially purified virus preparations were treated with
1 ug/ml of highly purified trypsin (Sigma, TPCK treated) in Dulbecco's
PBS at 37°C for 30 min.

The action of trypsin was stopped by the

addition of 1 ug/ml soybean trypsin inhibitor (Sigma) and incubation at
4°C for 30 min.

The virus suspension was centrifuged through a 2 ml 20%

sucrose-TNE cushion at 90,000 x g for 2 h.

Pellets were resuspended to

original volume in TNE.

VI.B.6.

Protein Quantitation

Protein concentrations were initially determined using the
protein-dye binding technique developed by Bradford (10).

The BioRad

Automated Protein Assay was employed in later experiments because this
technique required less sample to quantitate the protein.

In addition,

the procedure was simpler to perform, and the results were read more
rapidly.

VI.B.7.

Polyacrylamide Gel Electrophoresis (PAGE)

SDS-PAGE of virus samples was done using the Laemmli buffer system
(65).

Samples were dissociated by diluting 1:2 or 1:3 in buffer

containing B-mercaptoethanol, a reducing agent, or in the same buffer
lacking the reducing agent, then boiling for 5 min.

Gels containing 10%

or 12% bis-acrylamide were prepared in 1 mm thicknesses.

Gels were run

at a constant power of 4 watts/gel (approximately 25 mA/gel) for 3-4 h.
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BioRad low and high molecular weight standards were used:

lysozyme

(14,400), soybean trypsin inhibitor (21,500), carbonic anhydrase
(31,000), ovalbumin (45,000), bovine serum albumin (66,200),
phosphorylase B (92,500), B-galactosidase (116,250), myosin (200,000).
Proteins were visualized using the BioRad silver stain kit developed
according to the procedure of Merrill et al (86).

The Coomassie blue

protein stain was used in combination with the silver stain to identify
proteins which did not stain with silver.

VI.B.8.

Immunoblot Procedures

Immunoblots (Western blots) were done according to the procedure of
Burnette (16).

Briefly, proteins were separated by SDS-PAGE and

transferred to nitrocellulose membranes using Tris-glycine transfer
buffer (20 mM Tris base, 150 mM glycine), pH 8.3.

Transfer was

essentially complete after 18-20 h at 35 volts at approximately 10-15°C.
Transferred proteins were stained with Ponceau S (91), and molecular
weight markers were cut off and saved for use in determining molecular
weights of viral proteins.

Viral proteins were detected as follows:

Nitrocellulose membranes were immersed for 1-4 h in blocking solution
consisting of 5% Blotto (60) in Tris buffered saline (TBS) consisting of
10 mM Tris base and 0.9% NaCl, pH 7.4.

Primary antibody consisting of

anticoronavirus serum, obtained from an experimentally infected calf, in
TBS with 1% Blotto was added and allowed to incubate 16-18 h.

Excess

antibody solution was removed, and nitrocellulose was washed three times
for 5 min. each using TBS containing 0.05% Tween 20.

Goat antibovine

IgG (H + L chain), peroxidase conjugated, was obtained from Kirkegaard
and Perry Laboratories and diluted 1:5 in ELISA PBS + 0.1% human
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albumin.

The conjugate was diluted to a final concentration of 1:1000

in TBS, added to the membrane, and incubated for 2 h.

The membrane was

washed as described, and substrate consisting of 15 mg 4-chloronapthol
in 5 ml methanol, 25 ml 0.05 M Tris pH 6.8, 12 ul

was added.

After

optimal color development had occurred, the reaction was stopped by
rinsing with distilled water.

VI.C.
VX.C.l.

RESULTS
Comparison of the Polypeptide Structure of BCV-L9 Propagated in
Different Cells

The polypeptide composition of purified BCV-L9 propagated in D2BFS
cells with trypsin or in HRT-18 cells is revealed in Figure VI.1.
Proteins were visualized by double staining with silver followed by
Coomassie blue.

Coomassie blue was used to stain proteins which did not

stain with the silver reagent.

The profiles are compared in Table VI.1.

Common proteins of 140, 100, 52, 37, 34, 26, and 18-23 Kd were present
under non-reducing conditions, and a 62 Kd protein was present in D2BFSpropagated virus.

Distinctly different profiles were obtained under

reducing conditions.

In addition to common proteins of 95, 65, 52, 37,

34, 26 and 18-23 Kd, L9(HRT-18) had a 46 Kd protein that was not
observed in L9 (D2BFS).

The reduced profile of L9 (D2BFS) had unique

proteins of 93, 71, and 62 Kd.
The protein composition of partially purified BCV-L9 from HRT-18
cells and concentrated L9 from D2BFS cells without trypsin was detected
by Western blots (Fig. VI.2).

This technique allowed the detection of

high molecular weight proteins not observed by silver staining, since
higher concentrations of virus were used with the immunoblot procedure.
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The structural proteins of L9 produced in the two cell lines are
compared in Table VI.2.

Common proteins of 185, 140, 100, 52, 37, and

31-34 Kd were observed.

Notable differences included the following:

A

>200 Kd protein was found in D2BFS-produced virus, but not in virus
obtained from HRT-18.

This protein may be an uncleaved precursor or an

aggregate of viral proteins.

A 160 Kd protein was present in the L9

(D2BFS) profile but not L9 (HRT-18).

However, this protein was present

in the profile of L9 obtained from other HRT-18 parent and clone
preparations, and probably was not detected due to the concentration of
sample on the gel.

Interestingly, the 185 Kd protein was present in

high concentration in L9 (D2BFS), but in proportion to the other
proteins comprising the profile, it was present in low concentration in
L9 (HRT-18).

The 46 Kd protein was not detected in the HRT-18

preparation in this instance.
L9 was propagated in the four HRT-18 clones, partially purified, and
the proteins were separated by SDS-PAGE.
used to detect these proteins (Fig. VI.3).

Immunoblotting was the method
Under non-reducing

conditions common proteins of 185, 160, 140, 125, 100, 52, 46, 37,
31-34, and 26-28 Kd were fo'und in virus produced in clones 3F3, D2, and
3E3 (Table VI.3).
clone 4B3.

The 46 Kd protein was absent in L9 prepared from

Doublet bands of 110 and 100 Kd were found with L9 obtained

from clones 3F3, 3E3, and 4B3, whereas only a single 100 Kd band was
present in L9 from clone D2.

The profiles of L9 propagated in clones D2

and 3F3 are compared in Figure VI.4. to better illustrate this finding.
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VI.C .2.

Effect of Reducing Conditions on the Polypeptide Profile of
BCV-L9

Proteins of 140 and 100 Kd were consistently present in BCV-L9
preparations under non-reducing conditions.

The silver staining

technique revealed that these proteins disappeared under reducing
conditions with the concomitant appearance of 95 and 65 Kd proteins
(Figs. VI.1 and 6).

Three distinct bands of 23, 20, and 18 Kd were

converted to a cluster of bands ranging from 20-23 Kd by reducing agent
(Fig. VI.6).
The effect of reducing agent on the L9 profile was also examined by
Western blot, but this method failed to detect all reduced products
accurately (Fig. VI.3). The proteins of 185, 160, 140, 125, 110, and 100
Kd were not seen under reducing conditions and proteins of 190 and 65 Kd
were evident (Table VI.3).

VI.C.3.

Effect of Trypsin on BCV-L9 Polypeptides

BCV-L9 was propagated in D2BFS cells in the presence and absence of
trypsin.

Cell lysates were clarified and concentrated, and the viral

proteins were separated by SDS-PAGE under non-reducing conditions.
Following their transfer to a nitrocellulose membrane, viral proteins
were visualized by Western blotting (Fig. VI.5.).

Virus propagated

under trypsin-free conditions had the following profile:
140, 100, 52, 46, 37, and a 31-34 Kd cluster.

>200, 185,

The 185 Kd protein was

only faintly visible, the 160 Kd protein was not apparent, and the 100
Kd protein was present in higher concentration in L9 produced in D2BFS
in the presence of trypsin.

An additional difference between the

profiles was the absence of the 31-34 Kd cluster in trypsin-treated
virus.
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L9 was propagated in HRT-18 cells and purified, then treated in
vitro with trypsin.

The profiles of untreated and trypsin-treated L9

were examined under non-reducing and reducing conditions (Fig. VI.6).
The structural proteins observed under these conditions are compared in
Table VI.4.
identical.

In the absence of reducing agent, the profiles were
Detectable bands had molecular weights of 140, 100, 52, 27

23, 20, and 18 Kd.

Differences in the electrophoretic migration of

trypsin-treated and untreated viral proteins were evident only under
reducing conditions.

A 95 Kd protein was found in untreated virions,

while a 90 Kd protein was found in trypsin-treated virions.
Additionally, a cluster of 20-23 Kd proteins was found in untreated
virions, but this cluster ranged from 19-23 Kd with a 17 Kd protein in
trypsin-treated virions.
BCV-L9 propagated in clones 3F3 and 4B3 was treated in vitro with
trypsin and the profiles of trypsin-treated and untreated virus were
compared under non-reducing conditions (Fig. VI.7.).

The profile of L9

from clone 4B3 was unchanged with trypsin treatment.

Trypsin-treated L9

from clone 3F3 lacked the 46 Kd protein present in untreated virus.
addition, a band of approximately 25 Kd appeared.

In

The profiles of

trypsin-treated and untreated L9 from clone 3F3 were also compared under
reducing conditions (Fig. VI.8.).

Again the 46 Kd protein was absent

from trypsin-treated virions, and the 25 Kd protein was evident.

The

effect of trypsin on the high molecular weight proteins was undetermined
since these proteins were not readily detectable under reducing
conditions.

The effect of trypsin on the non-reduced profiles of L9 in

D2BFS cells, clone 3F3, and clone 4B3 are compared in Table VI.5.
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VI.D.

DISCUSSION

Host cell-dependent differences in the polypeptide profile of BCV-L9
were demonstrated in this investigation.

Notably, a 62 Kd protein was

evident by silver stain in a preparation of L9 propagated in D2BFS cells
with trypsin.

Trypsin was used in the propagation to increase the yield

of virus from D2BFS cells.

The 62 Kd protein may represent a cell-

specific viral protein or a trypsin cleavage product.

Western blot

analyses of L9 (D2BFS) preparations failed to detect this protein.

A

110-100 Kd doublet band was detected in L9 propagated in clones 3F3,
3E3, and 4B2, but only the 100 Kd species was evident from clone D2.
This difference may reflect a variation in processing or in
glycosylation of the protein.

A major protein of 46 Kd was evident in

virus raised in all cells except clone 4B3, which lacked the protein.
The function of this protein species is unknown, but the absence of the
protein may be the reason that relatively mild cytopathic expression
occurs in infected clone 4B3 (Chapters 3 and 4).
Storz and coworkers (unpublished results) detected host celldependent differences in the polypeptide profile of BCV-L9 by
radioiramune precipitation.

The virus was propagated in different cell

types in medium containing [^C] - labeled amino acids or [^S] methionine.

The proteins detected when the virus was propagated in

HRT-18 cells included 180, 82, 47, and 35 Kd species.

Using [^C] -

labeled amino acids, BCV from bovine fetal thyroid cells had proteins of
140, 100, 70, 52, and 47 Kd, while viruses propagated in the same cells
35
in the presence of [ S] - methionine had an 80 Kd migrating protein
species instead of the 70 Kd species.

BCV propagated in bovine fetal
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brain cells in the presence of [^C] - labeled amino acids or [^S] methionine had a composite profile of 140, 100, 60, 52, and 47 Kd.
Silver-stained gels revealed that the 140 and 100 Kd protein that
were present under non-reducing conditions disappeared under reducing
conditions.

At the same time, proteins of 95 Kd and 65 Kd appeared in

the presence of reducing agent.

Hogue and coworkers (46) found that the

140 Kd species consists of disulfide-linked subunits of 65 Kd.

They did

not observe a change in the electrophoretic migration of the 100 Kd
species under reducing conditions.

The 18, 20, and 23 Kd group of

proteins was converted to a 20-23 Kd cluster by reduction.

Western

blotting also revealed a change in the electrophoretic mobility of the
185 Kd protein to 190 Kd under reducing conditions.

Rather than

consisting of disulfide-linked subunits, the 185 and 100 Kd molecules
and the 18-23 Kd group of proteins probably contain intrachain disulfide
bonding.

In this case, reduction may alter the migration pattern by

breaking the intrachain bonds and allowing the proteins to be coated by
SDS more efficiently.

Consequently, the conformation of the intact

proteins would be different under reducing and non-reducing conditions,
which would influence the electrophoretic migration.
Silver staining was a superior method to Western blotting for the
detection of reduced L9 proteins.

An extended reaction time in the

substrate was required to visualize reduced proteins by Western
blotting.

The long incubation in substrate led to a high background and

made it difficult to discern the viral protein bands.

It was impossible

to determine the relationship between non-reduced and reduced proteins
by this method.

Since Western blotting depends on the antigenicity of
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proteins, it islikely that the viral proteins

were antigenically

altered when their conformation was changed by reduction.
The non-reduced form of virus is the disease agent in natural
infections of calves.

Therefore, it was considered more important to

examine the non-reduced profile of BCV.

The use of antiserum obtained

from an experimentally infected calf in Western blot procedures
indicated the antigenically active components of the virus.
Interestingly, the action of trypsin on the virus structure was
evident by silver stain only under reducing conditions.

This finding

indicates that trypsin-cleaved peptides were held intact by disulfide
bonds.

When reduced by B-mercaptoethanol, cleavage products were

separable.

Unique proteins of 93, 71, and 62 Kd were detected in

preparations of

L9 from D2BFS cells + trypsin. Trypsin-dependent bands

of 90 Kd and 17

Kdwere detected inL9 (HRT-18), and the 20-23 Kd

cluster found in untreated virions was converted to a 19-23 Kd cluster
by trypsin (Table VI.4).

In vitro trypsin-treated and untreated L9 from

clone 4B3 gave identical profiles.

Trypsin-treated L9 from clone 3F3

differed from untreated virus - the 46 Kd protein was not present in
treated virions, but a 25 Kd protein was found.

The 46 Kd protein must

be a surface component since it was accessible to trypsin.

The

relationship between the 46 and 25 Kd proteins has not been determined
conclusively, but the 25 Kd protein may be a cleavage product of the 46
Kd species.

Trypsin greatly enhances the cytopathic expression of L9 in

clone 3F3, but has little effect on the cytopathic changes of infected
4B3 cells (Chapters III and IV).

The cytopathic changes may be a

reflection of the trypsin-induced changes in polypeptide structure
observed here.
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The effect of trypsin on the polypeptide structure of L9 propagated
in D2BFS cells was examined because these cells fuse only in the
presence of trypsin.

The intent was to identify the viral protein(s)

responsible for cell fusion.

Under non-reducing conditions the 185 Kd

protein was present in high concentration in the absence of trypsin, but
only a faint band was present in virus produced with trypsin.

The 160

Kd protein was barely evident without trypsin and not seen with trypsin.
Concomitantly, the concentration of the 100 Kd species was much higher
in the presence of trypsin.

No additional proteins were found in virus

propagated with trypsin, but trypsin cleavage may have affected the
antigenicity of some proteins so that they were undetectable by Western
blotting.

For example, silver staining detected a 62 Kd protein when L9

was propagated in D2BFS cells with trypsin, but the protein was not
evident by Western blot detection.

These data strongly suggest that

cleavage of the 185 Kd protein to the 100 Kd form and/or other
undetected smaller species is required for activation of cell fusion.
In Fig. VI.2. the profiles of the virus raised in HRT-18 and D2BFS are
compared.

The 185 Kd species is present in proportionately low

concentration in L9 (HRT-18) as compared to L9 (D2BFS).

The protein was

also found in low concentration in virus obtained from the four clones.
Evidently, cleavage of ,the 185 Kd protein occurs by a cellular protease
in HRT-18 cells, while cleavage is less efficient in D2BFS cells.

These

cells require trypsin to cleave this protein and activate fusion.

This

finding is analogous to the MHV model.

With MHV-A59 a 180 Kd protein

must be cleaved by a cellular protease or by trypsin to activate the
fusing capacity of the virus (37,119).
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It appears that clone 4B3 is capable of cleaving the 185 Kd protein
(Fig. VI.2), but this cell line does not fuse.

The lack of fusion in

clone 4B3 may be a result of the composition of the plasma membrane of
these cells or other cellular characteristics, rather than the manner in
which these cells process the virus.
The 160 Kd protein may also be cleaved by trypsin since it was not
evident in the presence of trypsin.

However, the concentration of this

protein was so low in the absence of trypsin that its cleavage would not
have caused the dramatic increase in concentration of the 100 Kd
species.

It is possible that cleavage products of the 160 Kd protein

were not detectable.

In addition, a 31-34 Kd group of proteins was

found in the absence of trypsin, while a single 34 Kd species was found
in virus produced with trypsin.

These proteins must represent external

proteins since they were accessible to the enzyme.
Western blot detection allowed the identification of at least eleven
BCV-L9 structural proteins from HRT-18 cells.
following approximate molecular weight species:

The proteins include the
185 Kd, 160 Kd, 140 Kd,

125 Kd, 110 Kd, 100 Kd, 52 Kd, 46 Kd, 37 Kd, a 31-34 Kd group, and a
26-28 Kd cluster.

The 52 Kd species was the predominate protein.

The

140 and 125 Kd proteins were closely migrating species, as were the 110
and 100 Kd proteins.

When these proteins were present in high

concentration, as with L9 (D2BFS) (Figs. VI.2. and 5), or when poor
separation of high molecular weight proteins occurred, these proteins
were not resolved as individual species.

Rather, single, broad bands of

approximately 140 and 100 Kd were detected.
A group of proteins of 18-23 Kd was apparent on silver-stained 12%
gels under non-reducing conditions, while a concise cluster of 20-23 Kd
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was detected on reduced gels.
gels by Western blot.

These proteins were not detected on 10%

The 26-28 Kd proteins detected by Western blot

and the 18-23 Kd proteins detected by silver stain may represent the
same proteins with different migration patterns in 10 and 12% gels.
Hogue and coworkers (46) used a 5-15% gradient gel to pinpoint the
molecular weight of this cluster at 26 Kd.
The polypeptide profile of BCV-L9 propagated in HRT-18 cells was
also examined by other investigators (46,63,64,133).

The structural

proteins reported by these investigators, as well as those identified in
this study are compared in Table VI.6.

David Brian's group detected

high molecular weight species of 190, 140, 120, and 100 Kd.

These

proteins were identified as surface glycoproteins, with gp 140 serving
as hemagglutinin (64).

The investigators found that the 140 Kd species

consisted of disulfide-linked subunits of 65 Kd, a finding supported by
this investigation.

Hogue and coworkers (46) observed a 160 Kd band

which reacted with antiserura against pp 52.

They suggest that this

protein represents a trimer of the 52 Kd species.

Williams (133)

reported high molecular weight proteins of 182 and 109 Kd in

light

virions and 172 and 94.5 Kd in dense virions. Both profiles were
obtained under reducing conditions, making it difficult to compare these
profiles to those obtained in the present study.
A 52-53 Kd major protein was identified in all investigations of BCV
structure (46,63,64,133).

This protein is an internal phosphoprotein

which probably serves as nucleocapsid.

The nucleocapsid of nearly all

coronaviruses is a phosphoprotein of 48-52 Kd.
A cluster of proteins of approximately 26 Kd was reported by the
three groups of investigators.

King et al (64) demonstrated that this
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molecule is a surface glycoprotein, probably serving as a matrix
protein.

The clustering of the protein presumably indicates

glycosylation isomers with slightly varying molecular weights.

The

matrix protein of most coronaviruses is a glycoprotein of 20-29 Kd.
Additional proteins of 46, 37, and 31-34. Kd were also observed.
functions of these protein are unknown.

The

The 46 and 31-34 Kd proteins

were cleaved by trypsin, indicating that they are external proteins.
Williams (133) reported common proteins of 47 and 35 Kd in dense and
light virions.

A 20.5 Kd species was detected in light virions, and 21

and 15 Kd species were identified in dense virions.

Similar proteins

were detected in this study when the profiles were examined by silver
stain.

Dense and light forms of L9 were not separated in this

investigation.

Therefore, these analyses represent a composite of both

the dense and light profiles, probably contributing to the greater
complexity of the profiles detected in this study.
The MHV virion was thought to consist of only three structural
proteins originally - a 180 Kd peplomeric glycoprotein, a 50 Kd
nucleocapsid phosphoprotein, and a 23 Kd matrix glycoprotein.

Recently,

Sturman and coworkers (119) demonstrated that the 180 Kd protein is
actually comprised of two 90 Kd subunits, 90A and 90B, that are
distinctly different species.

Obviously, MHV is a more complex virus

than originally described, and further examination may reveal even
greater complexity.

In contrast, our investigation revealed at least

eleven structural proteins for BCV-L9.

The protein profiles depended on

the host cell used to propagate the virus and the detection system
applied.

For example, proteins of greater than 140 Kd were not detected

in silver-stained gels due to a low concentration of protein on the gel.
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Conversely, the 140 and 125 Kd proteins appeared as a single band from
D2BFS preparations since the high concentration of the proteins did not
allow them to be resolved separately.

There were differences in the

BCV-L9 profile obtained in this investigation as compared to those
reported by Williams (133), Hogue and coworkers (46), and King and
coworkers (63,64).
still unsettled.

Obviously, the protein composition of this virus is
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Table VI.1.

Polypeptide Profile of BCV-L9 Purified from HRT-18 or D2BFS

Cells as Detected by Silver Staining.

L9 (HRT-18)
reduced

L9 (D2BFS + trypsin)
non-reduced

reduced

non-reduced

140

140

100

100

95

95
93
71

65

65
62

62

52

52

52

52

46

46

37

37

37

37

34

34

34

34

26

26

26

26

18-23

18-23

18-23

18-23
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Table VI.2.

Comparison of the Structural Proteins of BCV-L9 Obtained

from HRT-18 and D2BFS Cells under Non-reducing Conditions as Detected by
Western Blotting.

L9 (D2BFS)

L9 (HRT-18)

>200
185

185

160
140

140

100

100

52

52

46
37
31-34

f

37
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Table VI.3.

Structural Proteins of BCV-L9 from HRT-18 Clones as

Detected by Western Blotting.

Non-reducing Conditions

Reducing Conditions

D2

3E3

3F3

4B3

D2

3E3

3F3

4B3

185

185

185

185

190

190

190

190

160

160

160

160

140

140

140

140

125

125

125

125

110

110

110

100

100

100

100

65

65

65

65

52

52

52

52

52

52

52

52

46

46

46

-

46

46

46

-

37

37

37

37

37

37

37

37

-

31-34

31-34

31-34

31-34

31-34

31-34

31-34

31-34

26-28

26-28

26-28

26-28

26-28

26-28

26-28

26-28
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Table VI.4.

Effect of Trypsin on the Polypeptide Profile of BCV-L9

Propagated in HRT-18 Cells as Detected by Silver Stain.

Trypsin (-)
Reduced

Trypsin (+)

Non-reduced

Reduced

Non-reduced

-

140

-

140

-

100

-

100

95

■-

90

-

65

-

65

-

52

52

52

52

46

-

46

-

37

37

37

37

34

34

34

34

31

27

31

27

-

23

19-23

23

20-23

20
18

17

20
18
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Table VI.5.

Effect of Trypsin on the Non-reduced Polypeptide Profile of

BCV-L9 Propagated in Different Cells as Detected by Western Blotting.

L9 (D2BFS)
Trypsin(-)

Trypsin(+)

L9 (3F3)

L9 (4B3)

Trypsin(-)

Trypsin(+)

Trypsin(-)

Trypsin (+)

>200

-

185

-

185

185

185

185

160

-

160

160

160

160

140

140

140

140

140

140

125

125

125

125

110

110

110

110

100

100*

100

100

100

100

52

52

52

52

52

52

46

46

46

-

-

-

37

37

37

37

37

37

31-34

31-34

31-34

31-34
25

* Increased in concentration

31-34

31-34

f

Table VI.6.

Comparison of Reported BCV-L9 Profiles from HRT-18 Cells.

Williams (133)

Brian (46, 63, 64)

Reducing Conditions

Reducing

Non-reducing

light virions

dense virions

conditions

conditions

182

172

>200

>200

190

190

St.Cyr-Coats (immunoblot detection)
Reducing

Non-reducing

conditions

conditions

190

185
160

109

94.5

-

120

140

140

120

125
110

100

100

65

-

65

52

52

52

52

100

53

53

47

47

46

46

35

35

37

37

22-26
20.5

22-26

26

26

31-34

31-34

26-28

26-28

21
109

15
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Figure VI. 1.

Polypeptide Profiles of BCV-L9 Propagated in
D2BFS Cells (+ trypsin) or HRT-18 Cells.
Proteins were detected by silver and Coomassie
staining.

12% acrylamide.

Virus in lanes B and

C was prepared with reducing agent.
F contained non-reduced virus.

Lanes E and

Lanes A, D, G -

molecular weight standards, Lanes B and E - L9
(HRT-18), lanes C and F - L9 (D2BFS).
indicate additional proteins.

Arrows

>
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A

Figure VI. 2.

B

C

Polypeptide Profiles of BCV-L9 Propagated in
D2BFS Cells and HRT-18 Cells as Detected by
Western Blotting.

Non-reduced.

10% acrylamide.

Lane A - L9 (HRT-18), lane B - L9 (D2BFS), lane
C - uninfected D2BFS cells.
differences in the profiles.

Arrows indicate
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Figure VI. 3.

Structural Proteins of BCV-L9 Propagated in
HRT-18 Clones as Detected by Western Blotting.
10% acrylamide.
virus.

Lanes A-E contained non-reduced

Lanes F-J contained reduced virus.

Lanes A and F - L9 (D2), lanes B and G - L9
(3E3), lanes C and H - L9 (3F3), lanes D and I L9 (4B3), lanes E and J - uninfected HRT-18
cells.

Arrows indicate missing bands.
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*

A

Figure VI. 4.

B

Structural Proteins of BCV-L9 Propagated in
HRT-18 Clones D2 and 3F3 as Detected by Western
Blotting.

Non-reduced.

10% acrylamide.

- L9 (D2), lane B - L9 (3F3).
differences in the profiles.

Lane A

Arrows indicate
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>200

A

Figure VI. 5.

B

C

Polypeptide Profiles of BCV-L9 Propagated in
D2BFS Cells in the Presence and Absence of
Trypsin as Detected by Western Blotting.
Non-reduced.

10% acrylamide.

Lane A - (-)

trypsin, lane B - (+) trypsin, lane C uninfected D2BFS cells.
structural differences.

Arrows indicate
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Figure VI. 6.

Structural Profiles of In Vitro Trypsin-Treated
and Untreated BCV-L9 Propagated in HRT-18 Cells
as Detected by Silver Staining.

12% acrylamide.

Lanes A and B contained non-reduced virus.
Lanes C and D contained virus prepared with
reducing agent.

Lanes A and C - trypsin-treated

virus, lanes B and D - untreated virus, lanes E
and F - molecular weight standards.
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Figure VI. 7.

Western Blot-Detected Protein Profile of In Vitro
Trypsin-Treated BCV-L9 Produced in Clones 3F3 and 4B3.
Non-reduced.

10% acrylamide.

Lane A - untreated L9

(4B3), lane B - trypsin-treated L9 (4B3), lane C trypsin-treated L9 (3F3), lane D - untreated L9 (3F3).
Arrows indicate structural differences.

117

Figure VI. 8.

Western Blot-Detected Protein Profile of In
Vitro Trypsin-Treated BCV-L9 Produced in Clone
3F3.

Reducing Conditions.

10% acrylamide.

Lane A - uninfected 3F3 cells, lane B untreated L9 (3F3), lane C - trypsin-treated L9
(3F3).

Arrows indicate structural differences.

CHAPTER VII.

SUMMARY AND PERSPECTIVES

Turbid plaques consisting of some apparently normal cells are
produced by BCV-L9 in HRT-18 monolayers.

This observation suggests that

the HRT-18 cell population is heterogeneous and consists of
subpopulations of cells with different susceptibility to BCV infection.
Immunofluorescent analysis of these plaques revealed that many cells
within the plaque do not express viral antigen, indicating that some of
the cells within the plaque are not infected by virus.
Four HRT-18 cell clones, 3F3, D2, 3E3, and 4B3, were characterized
according to morphology, growth kinetics, plating efficiency, and growth
in soft agar.

Cell monolayers examined by phase-contrast microscopy

exhibited distinct cell orientations which produced unique surface
topographies and patterns within the monolayers.
consistent and reproducible with subpassage.

These features were

Giemsa-stained cultures

revealed some variation in colony development at 24 h, with essentially
confluent monolayers at 7 2 h.
The kinetics of growth were determined from the growth curve
clone.

of each

The doubling times were distinct for each clone, but the

generation times were similar for clones D2, 3F3, and 4B3.
displayed a longer generation time.

Clone 3E3

A saturation density of

approximately 8 million cells was achieved by clones D2, 3E3, and 4B3,
but was about 1 million cells fewer for clone 3F3.

The plating

efficiencies of clone 3F3 and D2, 100% and 77%, respectively, were
significantly higher than those of clones 4B3 and 3E3, which were 50%
and 33%, respectively.

No significant differences were found in the

cells' ability to form colonies in soft agar, and efficiencies of 23%,
17%, 17%, and 15% were found for clones 3F3, 4B3, 3E3, and D2,
118
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respectively.
all clones had
The growth

The ability to form colonies in soft agar indicated that
transformed characteristics.
kinetics of clone 4B3 closely resembled those of the

HRT-18 parent cells at 55th passage.

However, clone 3F3 acted most like

the HRT-18 parent cells at low passage (122).

This finding may

represent the dominant influence of one cell type over the others in the
parent population at different passage levels.
HRT-18 cell clones were established by limiting dilution in an
attempt to isolate cell types which were either refractory or highly
susceptible to BCV infection.

The clones displayed differences in the

type and degree of cytopathic expression when
L9.

Clone 3F3

moderate CPE.

infected with BCV strain

produced extensive CPE, while clones D2 and 3E3 produced
In all three cases cytopathic changes included

cytoplasmic vacuolization and cell fusion.

In contrast, only mild CPE

occurred in infected clone 4B3, with no detectable cell fusion.
Based on these data it was concluded that the four HRT-18 clones are
distinctly different cell populations.

The basis for their differing

susceptibility to BCV infection was not determined in this
investigation.
The characterization of the HRT-18 cell clones could be expanded to
include other parameters.

For instance, the nucleic acid content of the

clones at 24, 100, and 124 h after seeding is presently being examined
by flow cytometry to assess putative differences between clones.

The

lack of cell fusion in BCV-infected clone 4B3 in the presence and
absence of trypsin may reflect the cells' inability to fuse rather than
the inactivity of the viral fusion factor.

The components of the plasma

membrane contribute to a cell's ability to fuse (109,110,111,112).
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Therefore, analysis of the biochemical make-up of the plasma membrane of
clone 4B3 in comparison to clone 3F3, which readily fuses when infected
with BCV, would be useful in determining a possible influence of the
cell membrane on the cells' ability to fuse when infected with BCV.
The effect of the virus strain, host cell, and trypsin modification
on the cytopathic expression and plaque development of bovine
coronavirus was analyzed.

HRT-18 parent cells, HRT-18 clones 3F3, D2,

3E3, and 4B3., and D2BFS cells were used to assay the growth of five wild
type BCV strains and strain L9.

All virus strains replicated in HRT-18

cells, inducing cell fusion to different degrees.

D2BFS cells were

non-permissive to all wild-type BCV strains, but L9 replicated in these
cells.

Trypsin enhanced the cytopathic expression, activating cell

fusion in D2BFS cells.

The CPE varied in L9-infected HRT-18 clones.

Trypsin enhanced CPE and cell fusion in clones 3F3, D2, and 3E3, but not
in clone 4B3.
clones.

The plaque development of strain L9 varied in the four

Plaques were readily produced in clone 3F3, and these were

dramatically enhanced by trypsin.

The diameter of the plaques increased

significantly, plaques became less turbid and more distinct, and they
developed more rapidly in the presence of trypsin.

Plaques developed

less efficiently in the other three clones, with trypsin enhancing
plaque development only marginally.

No plaques were produced in clone

4B3 cells infected with wild-type virus strains, but plaques developed
in clone 3F3.

Strains Meeker, Miller, Fisher, Calf 50, and LY-138

produced different plaque phenotypes in clone 3F3, and in all cases the
plaques were enhanced by trypsin.
The effect of trypsin on the infectivity of BCV-L9 propagated in
different host cells was analyzed.

The virus was propagated in the
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presence and absence of trypsin, and PFU:HA ratios at virus dilutions
10

“2

-10

*"6

were compared.

The infectivity of the virus was enhanced to

infinite proportions at high dilutions in both D2BFS cells and HRT-18
cells, but the increase was evident at a 100-fold lower dilution in
D2BFS cells.

Limited trypsin enhancement of infectivity occurred in

clones D2, 3E3, and 3F3 which displayed PFU:HA ratios in the presence or
absence of trypsin of 2:1, 3:1, and 5:1, respectively.

Trypsin caused a

decrease in infectivity of L9 propagated in clone 4B3.

Additionally,

strain LY-138 was assayed in HRT-18 parent cells.

An infectivity

increase of less than 1 log unit was obtained at the highest dilution of
virus.

These data indicate that the infectivity of BCV was affected by

the strain of virus, host-dependent factors, and by trypsin.
Host cell-dependent differences in the non-reduced polypeptide
profile of BCV-L9 were identified.

A 62 Kd protein was evident by

silver stain from L9 propagated in D2BFS cells with trypsin.
protein was not detected in L9 (HRT-18).

This

The protein may be a

cell-specific viral protein or a trypsin cleavage product.
protein was not detectable by Western blot.

The 62 Kd

A 46 Kd protein was present

in L9 produced in all cell types except clone 4B3.

L9 propagated in

clones 3F3, 3E3, and 4B3 had a doublet of 110 and 100 Kd proteins, but
only a single 100 Kd band was detected in L9 (D2). The two species may
represent glycosylation isomers, such as those found at 26 Kd, or
different cleavage products, but their relationship is undetermined.
The 140 Kd protein was reduced to a 65 Kd species, an observation
previously reported by Hogue and coworkers (46).

Additionally, the 185

Kd protein migrated as a 190 Kd species, and the 100 Kd protein migrated
as a 95 Kd species in the presence of reducing agent.

Changes in the
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electrophoretic migration of these proteins may reflect intrachain
disulfide bonding as discussed in the previous chapter.

The 18, 20, and

23 Kd molecules were converted to a 20-23 Kd cluster under reducing
conditions.

The relationship of reduced and non-reduced proteins was

not discernable by Western blot.

The antigenic configuration was

probably altered by reducing conditions making the reduced products less
antigenic in the blotting procedure.
L9 propagated in D2BFS cells with and without trypsin were compared
under non-reducing conditions by Western blotting.
in the two profiles included the following:

Notable differences

The 185 Kd protein was

present as a broad band in virus produced without trypsin, but the
protein was nearly inapparent in L9 propagated with trypsin.

Coincident

with the disappearence of the 185 Kd species was a significant increase
in the 100 Kd protein.

The precursor-product relationship of the two

species must be examined either by tryptic peptide mapping or with
monospecific antiserum against the 185 Kd species.

Since L9-infected

D2BFS cells fuse only in the presence of trypsin, cleavage of the 185 Kd
protein to the 100 Kd form probably activates the fusion factor, but
other undetected cleavage products, such as the 62 Kd protein, may be
involved in cell fusion.

In addition, the 31-34 Kd cluster was present

as a single 34 Kd protein in the presence of trypsin, indicating that
these proteins are an external component since they were accessible to
trypsin.
Trypsin cleavage products of L9 propagated in HRT-18 cells or D2BFS
cells with trypsin were evident in silver-stained gels only under
reducing conditions.
by disulfide bridges.

Evidently, the cleaved proteins were held intact
Trypsin-dependent bands of 93, 71, and 62 Kd
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were identified in the L9 (D2BFS + trypsin) preparations, and a 90 Kd
trypsin-dependent band was obtained from L9 (HRT-18).

The 93 and 90 Kd

species are possibly the same protein which migrated differently on
different gels.

Trypsin also acted on the 20-23 Kd cluster seen in the

L9 (HRT-18) preparation, converting it to the 19-23 Kd range.
In vitro trypsin-treated L9 obtained from clones 4B3 and 3F3 were
compared to untreated virus.
(4B3) were not detected.

Changes in the polypeptide profile of L9

The 46 Kd protein was present in untreated L9

(3F3) but absent in trypsin-treated virions.

Concomitantly, a 25 Kd

protein appeared in the treated preparation.

The precursor-product

relationship of the 46 and 25 Kd proteins must be analyzed before a
correlation between the two species can be determined.
At least eleven structural proteins of BCV-L9 were identified.
These proteins had approximate molecular weights of 185, 160, 140, 125,
110, 100, 52, 46, 37, 31-34, and 26-28 Kd, but the profile of BCV-L9
showed differences depending on the host cell used for propagating the
virus and the detection system employed.

Hogue et al (46) and King and

coworkers (63,64) identified high molecular weight glycoproteins of 190,
140, 120, and 100 Kd which are surface proteins.

It was our experience

that when the protein concentration was high on the gels or when poor
separation of the proteins occurred, then the 160 Kd protein was not
distinguishable from the 185 Kd protein; the 140 and 125 Kd proteins
appeared as a single broad band that migrated at 140 Kd;

and the 110 and

100 Kd proteins were not resolved and appeared as a single, broad 100 Kd
band.

Consequently, detection of all the viral proteins

optimal protein load and running conditons.

required an
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The high molecular weight proteins identified by Williams (133) can
not be accurately compared to our profile since Williams performed his
experiments under reducing conditions.

The two virus phenotypes

observed by Williams were not analyzed separately in our
experimentation.

Rather, our analysis represents a composite profile of

the two BCV phenotypes, probably contributing to the greater complexity
of our virus profile.
David Brian's group (46,63,64) identified the 140 Kd protein as the
hemagglutinin and suggested that the 52 Kd and 26 Kd species are
nucleocapsid and matrix proteins, respectively.

Using anti-pp 52

antiserum in immunoblots, these investigators detected a 160 Kd species
in some BCV preparations. They assumed that the protein represents a
triraer of pp 52 (46).
undetermined.

The functions of our additional proteins are

The location and functions of the constituent viral

proteins could be determined by in vitro enzymatic iodination of intact
and disrupted virions.

With intact virions, only external proteins

would be iodinated, while internal proteins would also be labeled using
disrupted virions (63).
While it was important to examine the reduced profile of BCV to
determine the subunit structure of the virus, the non-reduced virus is
the form of virus which causes disease in the natural infection.
Iramunoblot detection of the non-reduced viral proteins was conducted
using antiserum obtained from an experimentally infected calf.

This

technique allowed the identification of the immunogenic viral proteins,
and provided information about the form of virus presented to and
recognized by the host humoral immune system.

It is possible that other

viral proteins were not detected due to a loss of antigenicity through
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heat denaturation, SDS-treatment, transfer to nitrocellulose, or other
procedures used to separate and analyze the proteins.
A hypothetical model of the structure of BCV-L9 is proposed based

on

the data obtained from these investigations and those previously
reported (46,63,64,133) (Fig. VII.1).

This model depicts the viral

proteins identified under non-reducing conditions, since this form of
virus is the infectious agent in nature.
In the infectious form the 185 Kd peplomeric protein is cleaved to
100 Kd.

This study has revealed that processing of the 185 Kd protein

occurs either by cellular proteases or by trypsin.

HRT-18 cells and

clones 3F3, 3E3, D2, and 4B3 were capable of efficient cleavage of the
protein.

Conversely, the 185 Kd protein was only partially cleaved in

D2BFS cells, and trypsin was required for complete cleavage of the
protein.

As a result, cell fusion occurred in BCV-L9-infected D2BFS

cells only in the presence of trypsin.
Brian's group (46,63,64) proposed that the 140, 120, and 100 Kd
proteins were surface glycoproteins.
peplomeric protein as well.

Our 110 Kd molecule

is probably a

The protein may represent an additional

cleavage product of the 185 Kd species, or the 110 and 100 Kd bands may
be glycosylation isomers.
The nucleocapsid protein of BCV-L9 has a molecular weight of 52 Kd.
Hogue and coworkers (46) suggested that the 160 Kd protein is a trimer
of this species since it cross reacts with monospecific antiserum
directed against pp 52.

The 26-28 Kd cluster presumably represents

glycosylation isomers of the matrix protein.
also comprise the matrix.

The 31-34 Kd cluster may

126
The 140 Kd protein consists of disulfide-linked subunits of 65 Kd
(46,63,64).

Our data indicates that intrachain disulfide linkages are

present in the 185, 100, 26-28, and 31-34 Kd proteins.
Undefined proteins of 46 and 37 Kd were identified.

The 46 Kd

protein is probably an external protein since it was cleaved by trypsin
in some preparations.

Trypsin had no effect on the electrophoretic

migration of the 37 Kd species.

Although the data are insufficient to

accurately position these proteins, they have been incorporated into the
hypothetical model.
There is tremendous diversity in the recognized polypeptide
composition of different coronaviruses, and the complexity of these
viruses is emerging.

For instance, three structural proteins were

originally identified for MHV, but four proteins are now accepted.

A

number of coronaviruses are considered to consist of four proteins
including DVIM, HCV-OC43, TGEV, and others (41,46,120), while up to nine
proteins are found with HECV-24 and 35 (5).

As demonstrated in these

investigations, the structural composition of bovine coronaviruses is
far from settled.

Inevitably, the accepted profiles of many

coronaviruses will change as experimentation progresses.
The data presented in this manuscript have significant implications
for the continuing study of coronavirus-host relationships, virulence of
BCV, and prevention of disease.

Cell types with different

susceptibility to BCV infection were identified.

Varied cytopathic

expression of the virus in the HRT-18 clones and D2BFS cells were
correlated to differences in the structural profile of the virus.
Proteins which potentially contributed to cytopathic expression and
infectivity of the virus were identified.
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The different cell types could be further examined to identify
cellular factors, such as proteases, which contribute to the production
of infectious virus.

At the same time, cellular resistance factors

could be determined.
Trypsin enhanced the CPE and infectivity of BCV and altered the
polypeptide profile of the virus.

Since trypsin is a constituent

digestive enzyme of the intestinal tract, it may influence BCV virulence
in natural infections.

If this is the case, inhibition of trypsin

action in the gut may be a useful method for prevention of infection in
newborn calves.

However, it would be necessary to devise such a

treatment without disrupting the digestive process of the animal.
Wild-type BCV strains displayed differences in CPE and plaque
formation with and without trypsin.

These viruses also have some

differences in their polypeptide profiles (132).

These strains may vary

in their ease of processing to the infectious form by trypsin or
cellular proteases.

This observation possibly reflects a viral

virulence factor in cases of natural infection.
The structural profile of BCV-L9 was determined, revealing that BCV
is a complex virus.

Knowledge of the prevalence, stability, and

antigenicity of the viral proteins is important in the development of
viral vaccines - especially when developing inactivated, recombinant, or
synthetic peptide vaccines.
Cleavage of the 185 Kd precursor protein to the 100 Kd form
correlated to activation of cell fusion and enhanced viral infectivity.
Therefore, the 100 Kd protein is most likely the viral fusion factor,
the protein responsible for cell to cell spread of infection.
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Figure VII. 1.

Hypothetical Model of Bovine Coronavirus Strain L9

Chapter VIII.
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